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Abstract: Several analogues of Isomeridianin G have been 
synthesized using as a key step palladium-catalyzed cross-
coupling reactions of lithium triorganozincates. The latter have 
been prepared by deprotonative lithiation followed by 
transmetalation using ZnCl2·TMEDA (1/3 equiv). 
Key words: Cross-coupling, Heterocycles, Palladium, Zinc, 
Lithium. 
The importance of heterobiaryls in compounds of biological 
interest have stimulated tremendous efforts for the 
development of synthetic methods in the area of aryl-aryl 
bond formation.
1







 cross-couplings between 
organozincs and aryl halides are known to tolerate 
numerous functional groups. When compared with the first 
reactions, the latter become attractive when heteroaryl 
boronic acids cannot be prepared, furthermore they do not 
require highly toxic starting materials. 
The organozincs are often prepared by reacting the 
corresponding lithium or magnesium compounds with zinc 
halides.
5
 A drawback of the Negishi coupling procedure lies 
in the fact that dry zinc chloride or zinc bromide is 
required. 
Miller and Farrell reported the use of a catalytic amount of 
zinc chloride to perform nickel- or palladium-catalyzed 
couplings of aryl Grignard reagents with aryl halides.
6
 
Other studies avoided the use of a zinc salt by generating 
lithium zincates either by iodine-metal exchange
7
 or by 
deprotonation.
8
 In 2002, Gauthier and co-workers 
documented an approach through lithium zincates using 
only one third equivalent of zinc chloride for the synthesis 
of 5-aryl-2-furaldehydes from 5-lithio-2-furaldehyde 
diethyl acetal.
9
 In addition, Mutule and Suma described in 
2005 one pot Grignard formation-transmetalation-Negishi 




We have recently published palladium-catalyzed Negishi 
reactions
11
 for which the lithium triarylzincates were 
generated by transmetalation of the corresponding lithio 
compounds using ZnCl2·TMEDA.
12
 Herein, we report the 
whole study, as well as the use of the deprotonation-
transmetalation-coupling sequence as a key step for the 
synthesis of molecules of biological interest. 
For this present study, numerous lithio aromatics obtained 
by deprotonation were transmetalated using 1/3 equivalent 
of ZnCl2·TMEDA. The lithium triarylzincates generated 
were then involved in cross-coupling reactions with 
aromatic halides using catalytic amounts of palladium(II) 






 were used (Table 
1). Thiophene was lithiated using butyllithium in 
tetrahydrofuran (THF) at –75 °C,15 before the 
transmetalation step to generate lithium tri(2-
thienyl)zincate. The subsequent palladium-catalyzed cross-
coupling was performed with 4-bromoanisole, 4-
bromonitrobenzene, methyl 4-bromobenzoate and 4-
bromobenzonitrile at 55 °C to afford the corresponding 
derivatives 1a-d in yields ranging from 10
16
 to 79% (entries 
1-4). It was noticed that reactions performed with the 
corresponding chlorobenzenes, which have higher carbon-
halogen bond dissociation energies,
17
 failed. N-Boc indole 
was deprotonated upon treatment with lithium 2,2,6,6-
tetramethylpiperidide (LiTMP) in THF at 
–90 °C,18,19 and then treated similarly to provide the 
expected substituted N-Boc 2-phenylindoles 2a-c (entries 5-
7). These conditions also proved suitable for the 
functionalization of 5-fluoro and 5-bromo N-Boc indoles 
(compounds 3, 4a-b, entries 8-10). 
Table 1 Coupling Reactions of Lithium Triarylzincates with 
Substituted Phenyl Bromides 
Ar
1) base, THF, Temp, 1 h
2) ZnCl2·TMEDA (1/3 equiv), r.t., 1 h
3)
PdCl2 (2%), dppf (2%)
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 were also used to prepare 
bis(heterocycles) (Table 2). The 2-lithio benzo[b]furan 
derivative was prepared using butyllithium in THF at –15 
°C,
21
 and converted to the corresponding lithium 
arylzincate. Subsequent cross-coupling with 2,4-
dichloropyrimidine and 2-chloropyridine provided the 
expected bis(heterocycles) 5a,b in satisfying yields (entries 
1,2).
22,23
 The furylpyrimidine 6 was prepared similarly 
(entry 3).
24
 Benzo[b]thiophene, thiophene and 2-
chlorothiophene were deprotonated using butyllithium at 
–75 °C,15 and the lithio derivatives gave the corresponding 
coupled products 7a-b, 1e and 8 (entries 4-7). N-Boc 
pyrrole was deprotonated upon treatment with LiTMP in 
THF at –75 °C25 to give the pyridyl and pyrimidyl 
derivatives 9a-b after subsequent transmetalation-coupling 
reactions (entries 8,9). The syntheses of the 2-indolyl-
pyridine 2e and -pyrimidines 2d,10-13 were performed 
from different 2-lithiated N-Boc indoles generated by 
deprotonation using LiTMP at –90 °C (entries 10-15). 
Anisole was similarly ortho-functionalized after direct 
lithiation at 25 °C
26
 to afford the 2-pyridyl derivative 14 
(entry 16). The reaction also proved convenient for the 
functionalization of a -deficient substrate, 2-
fluoropyridine, which was converted to the unsymmetrical 
bipyridine 15 (entry 10) after lithiation using LiTMP in 
THF at –75 °C,27 followed by transmetalation and cross-
coupling steps. 





1) base, THF, Temp, 1 h
2) ZnCl2·TMEDA (1/3 equiv), r.t., 1 h
3)
PdCl2 (2%), dppf (2%)
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 Since 2,4-dichloropyrimidine rapidly reacts with air damp, lower 
yields can be partly attributed to the presence of pyrimidinone in the 
starting heteroaryl chloride. 
c
 2 h instead of 1 h. 
Meridianins are a family of compounds isolated and 
characterized from the south atlantic tunicate Aplidium 
Meridianum.
28
 Some of them proved to inhibit GSK-3 
(Glycogen Synthase Kinase),
29
 a kinase involved in the 
abnormal phosphorylation of tau protein and the production 
of  amyloid, two processes implicated in Alzheimer’s 
disease
30
 (Scheme 1). 
Meridianin B (R1 = OH, R2 = Br, 
R3 = H): 0.5 M
Meridianin E (R1 = OH, R2 = H,














Isomeridianin C (R = Br): > 1000 M
Isomeridianin G (R = H): 420 M
 
Scheme 1 Inhibition Activities (IC50) at GSK-3 of Meridianins B and 
E, and Isomeridianins C and G 
The method we developed proved suitable to prepare 
Isomeridianin G as well as different analogues.
31
 The 
replacement of the indole ring by other five-membered 
aromatic heterocycles was first considered. To this purpose, 
the chloro group of 2-chloropyrimidyl compounds 2d, 9a, 
5a, 6, 7a and 1e was substituted with allylamine to afford 
the derivatives 16-21 after subsequent cleavage of the allyl 
group under classical conditions
32
 (Table 3). 
Table 3 Synthesis of Isomeridianin G and Pyrimidine Analogues 
MeSO3H, 10% Pd/C




























































































 Cleavage of the Boc protection occured during the first step. 
The replacement of the pyrimidine group by other six-
membered ring aromatics was then considered. This was 
achieved by cleavage of the Boc protective group of 
coupled compounds using either trifluoroacetic acid (TFA) 
in dichloromethane at r.t.
33
 or tetrabutylammonium fluoride 
(TBAF) under reflux of THF
34
 to provide the indole 
analogues 22-28 (Table 4). 
Table 4 Synthesis of Indole Analogues 
TFA, CH2Cl2
r.t., 2 h (A)
TBAF, THF













































































































Finally, analogues containing both indole and pyrimidine 
rings with diverse amino groups on the 2-position of the 
4 Synthesis  
Template for SYNLETT and SYNTHESIS © Thieme  Stuttgart · New York 2013-01-28 page 4 of 18 
pyrimidyl ring were synthesized from the chloro compound 
2d. The substitution of the chloro group was performed 
using a large range of amines under microwave irradiation
35
 
after initial Boc cleavage using TFA. 
The GSK-3 inhibition activity (IC50 values) of the 
Isomeridianin G analogues 16-47 was evaluated. While 
most of the compounds were showing a weak activity (IC50 
> 27 M), analogues 29, 31, 33, 44 and 46 were however 
found to inhibit GSK-3 in the 5-25 M range (Table 5). 
Table 5 Synthesis of Both Pyrimidine and Indole Analogues of 
Isomeridianin G, and Inhibition Activities at GSK-3. 
RNH2
pyridine / EtOH






































































































































































































































































































































In conclusion, several analogues of Isomeridianin G have 
been synthesized and evaluated as GSK-3 inhibitors. 
The key step of their synthesis is a palladium-catalyzed 
cross-coupling between an aromatic halide and a lithium 
triorganozincate which has been prepared by deproto-
lithiation followed by transmetalation using 
ZnCl2·TMEDA (1/3 equiv). As compared with 
Isomeridianin G (IC50 = 420 M), the inhibition activity 
at GSK-3 has been greatly improved, with an IC50 
value of 4.9 M for the best compound 44. It would be 
interesting to make further analogues of compound 44 
containing an hydroxy group at the 4-position or/and a 
bromo group at the 6- or 7-position, such as Meridianin 
templates. 
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Metalation reactions were performed under argon atmosphere. 
THF was distilled over sodium/benzophenone. LiTMP was pre-
pared in situ in THF at 0 °C from 2,2,6,6-tetramethylpiperidine 
and butyllithium, and a 1.6 M butyllithium in hexanes solution 
was used. ZnCl2·TMEDA was prepared as described previously.
36 
Column chromatography separations were achieved on silica gel 
(40–63 m). Mass-Directed AutoPreparative HPLC (MDAP) were 
performed using a Waters ZQ instrument with H2O/acetonitrile as 
a gradient. Melting points were measured on a Kofler apparatus. 
1H and 13C Nuclear Magnetic Resonance (NMR) spectra were 
recorded on a Bruker ARX-200 spectrometer at 200 and 50 MHz, 
respectively, on a Bruker Avance III spectrometer at 300 and 75 
MHz, respectively, or even on a Bruker AC-400 spectrometer at 
400 and 100 MHz, respectively. 1H chemical shifts () are given in 
ppm relative to the solvent residual peak, and 13C chemical shifts 
relative to the central peak of the solvent signal.37 Low resolution 
mass spectra measurements were performed using a Waters ZQ 
instrument in ElectroSpray Chemical Ionization (ESCI) mode. 
High Resolution Mass Spectra (HRMS) measurements and ele-
mental analyses were performed at the CRMPO (Centre Régional 
de Mesures Physiques de l’Ouest) of Rennes using a Micromass 
MS/MS ZABSpec TOF instrument in EI mode and a Thermo-
Finnigan Flash EA 1112 CHNS analyzer, respectively. The reac-
tions under microwave irradiation were performed in a Biotage 
Initiator instrument. Kinase inhibition activity at GSK-3 of 
Isomeridianin G and analogues was measured at GlaxoSmithKline 
R&D Harlow from an in-vitro assay, following an in-house proce-
dure. 
General Procedure for the Synthesis of N-Boc Protected In-
doles.19 
To a stirred solution of the required indole (35 mmol) in CH2Cl2 
(70 mL) were successively added pyridine (3.7 mL, 45 mmol), 
Boc2O (9,9 g, 45 mmol) and DMAP (0,43 g, 3,5 mmol). The 
mixture was stirred for 24 h at r.t. before addition of an aq sat. 
solution of NH4Cl (50 mL) and extraction with EtOAc (3 x 50 
mL). The combined organic layers were dried over Na2SO4, fil-
tered and concentrated under reduced pressure before purification 
by chromatography on silica gel (the eluent is given in the product 
description). 
N-Boc indole. 
Eluent: heptane/CH2Cl2 50/50. 
Yield: 67% (5.1 g). 
Colourless oil. 
1H NMR (200 MHz, CDCl3):  1.67 (s, 9H), 6.56 (d, 1H, J = 3.5 
Hz), 7.17-7.40 (m, 2H), 7.56 (m, 1H), 7.60 (d, 1H, J = 3.5 Hz), 
8.19 (d, 1H, J = 8.1 Hz). 
13C NMR (50 MHz, CDCl3):  28.3 (3C), 83.7, 107.4, 115.3, 
121.1, 122.8, 124.3, 126.0, 130.7, 135.3, 149.9. 
The spectral data were found identical to those of a commercial 
sample. 
N-Boc 5-nitroindole.38 
Eluent: hexane/CH2Cl2 95/5 to 50/50. 
Yield: 99% (9.0 g). 
White powder. 
Mp 115 °C. 
1H NMR (400 MHz, CDCl3):  1.65 (s, 9H), 6.71 (d, 1H, J = 4.0 
Hz), 7.73 (d, 1H, J = 4.0 Hz), 8.19 (dd, 1H, J = 9.2, 2.4 Hz), 8.26 
(d, 1H, J = 9.2 Hz), 8.48 (d, 1H, J = 2.4 Hz). 
13C NMR (100 MHz, CDCl3):  28.3 (3C), 85.4, 108.1, 115.5, 
117.5, 119.7, 129.1, 130.5, 138.5, 143.9, 149.2. 
ESCI MS: m/z 262.81, [M+H]+; 206.77. 
Anal. Calcd for C13H14N2O4 (262.26): C, 59.54; H, 5.38; N, 10.68. 
Found: C, 59.53; H, 5.33; N, 10.44%. 
N-Boc 5-cyanoindole. 
Eluent: hexane/CH2Cl2 95/5 to 50/50. 
Yield: 97% (8.2 g). 
White powder. 
Mp 128 °C (lit.39 128-129 °C). 
1H NMR (400 MHz, CDCl3):  1.68 (s, 9H), 6.62 (dd, 1H, J = 3.9, 
0.9 Hz), 7.56 (dd, 1H, J = 8.5, 1.7 Hz), 7.70 (d, 1H, J = 3.9 Hz), 
7.89 (dd, 1H, J = 1.7, 0.9 Hz), 8.25 (d, 1H, J = 8.5 Hz). 
13C NMR (100 MHz, CDCl3):  28.3 (3C), 85.2, 106.3, 107.2, 
116.2, 120.1, 126.0, 127.6, 128.3, 130.7, 137.3, 149.3. 
ESCI MS: m/z 242.92, [M+H]+; 186.90. 
Anal. Calcd for C14H14N2O2 (242.27): C, 69.41; H, 5.82; N, 11.56. 
Found: C, 69.38; H, 5.79; N, 11.58%. 
The spectral data were found identical to those previously de-
scribed.39 
N-Boc 4-methoxyindole. 
Eluent: hexane/CH2Cl2 95/5 to 50/50. 
Yield: 88% (7.5 g). 
Colourless oil. 
1H NMR (400 MHz, CDCl3):  1.67 (s, 9H), 3.94 (s, 3H), 6.67 (d, 
1H, J = 7.9 Hz), 6.69 (dd, 1H, J = 3.9, 0.9 Hz), 7.23 (dd, 1H, J = 
8.3, 7.9 Hz), 7.50 (d, 1H, J = 3.9 Hz), 7.75 (d, 1H, J = 8.3 Hz). 
13C NMR (100 MHz, CDCl3):  28.4 (3C), 55.6, 83.9, 103.2, 
104.5, 108.5, 121.0, 124.6, 125.3, 136.7, 150.1, 153.1. 
Anal. Calcd for C14H17NO3 (247.29): C, 68.00; H, 6.93; N, 5.66. 
Found: C, 67.99; H, 6.87; N, 5.64%. 
N-Boc 4-bromoindole. 
Eluent: hexane/CH2Cl2 100/0 to 50/50. 
Yield: 91% (9.4 g). 
Colourless oil. 
1H NMR (400 MHz, CDCl3):  1.67 (s, 9H), 6.64 (d, 1H, J = 3.9 
Hz), 7.16 (dd, 1H, J = 8.3, 7.9 Hz), 7.39 (dd, 1H, J = 7.9, 0.9 Hz), 
7.64 (d, 1H, J = 3.9 Hz), 8.11 (d, 1H, J = 8.3 Hz). 
13C NMR (100 MHz, CDCl3):  28.3 (3C), 84.5, 107.3, 114.4, 
114.9, 125.3, 125.7, 126.7, 131.3, 135.8, 149.7. 
Anal. Calcd for C13H14BrNO2 (296.16): C, 52.72; H, 4.76; N, 
4.73. Found: C, 52.70; H, 4.66; N, 4.72%. 
N-Boc 5-fluoroindole. 
Eluent: heptane/CH2Cl2 60/40. 
Yield: 70% (5.7 g). 
Colourless oil. 
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1H NMR (200 MHz, CDCl3):  1.67 (s, 9H), 6.52 (d, 1H, J = 3.7 
Hz), 7.03 (ddd, 1H, J = 9.2, 9.0, 2.5 Hz), 7.21 (dd, 1H, J = 9.2, 2.5 
Hz), 7.63 (d, 1H, J = 3.7 Hz), 8.09 (dd, 1H, J = 9.0, 4.5 Hz). 
These data were found identical to those previously described.40 
13C NMR (50 MHz, CDCl3):  28.4 (3C), 84.1, 106.5 (d, J = 23 
Hz), 107.1 (d, J = 3.9 Hz), 112.2 (d, J = 25 Hz), 116.2 (d, J = 9.3 
Hz), 127.6 (2C), 131.6 (d, J = 10 Hz), 149.7, 159.4 (d, J = 239 
Hz). 
N-Boc 5-bromoindole. 
Eluent: heptane/CH2Cl2 60/40. 
Yield: 97% (10 g). 
Brown-purple powder. 
Mp 56 °C. 
1H NMR (200 MHz, CDCl3):  1.67 (s, 9H), 6.51 (d, 1H, J = 3.5 
Hz), 7.39 (dd, 1H, J = 9.1, 2.0 Hz), 7.59 (d, 1H, J = 3.5 Hz), 7.68 
(d, 1H, J = 2.0 Hz), 8.02 (d, 1H, J = 9.1 Hz). 
13C NMR (50 MHz, CDCl3):  28.3 (3C), 84.3, 106.7, 116.2, 
116.8, 123.7 (2C), 127.2, 132.4, 134.1, 149.6. 
These data were found identical to those previously described.41 
General Procedure for the Deprotonation/Cross-coupling 
Sequence (Compounds 1a,c-e, 2a-e, 3, 4a,b, 5a, 6, 7a,b, 8, 9a-b, 
10-15). 
To a stirred and cooled solution (temperature given in the product 
description) of the appropriate reagent (4.0 mmol) in dry THF (5 
mL) under argon were added the required base (4.0 mmol) and, 1 
h later, ZnCl2·TMEDA
35 (0.33 g, 1.3 mmol). The mixture was 
slowly warmed to r.t. (1 h) before addition of the appropriate 
aromatic halide (4.0 mmol), PdCl2 (14 mg, 80 mol) and dppf (44 
mg, 80 mol), and heated at 55 °C for 12 h. The mixture was 
cooled before addition of water (0.5 mL). Extraction with EtOAc 
(2 x 25 mL), drying over Na2SO4, and removal of the solvents 
under reduced pressure afforded a crude compound which was 
purified by chromatography on silica gel (the eluent is given in the 
product description). 
2-(4-Methoxyphenyl)thiophene (1a) was prepared from thio-
phene (0.32 mL) using BuLi at –75 °C and 4-bromoanisole (0.50 
mL). 
Eluent: heptane/CH2Cl2 100/0 to 95/5. 
Yield: 10% (67 mg). 
Beige powder. 
Mp 104 °C. 
1H NMR (200 MHz, CDCl3):  3.84 (s, 3H), 6.92 (d, 2H, J = 8.8 
Hz), 7.05 (dd, 1H, J = 5.0, 3.5 Hz), 7.21 (m, 2H), 7.55 (d, 2H, J = 
8.8 Hz). 
13C NMR (50 MHz, CDCl3):  55.3, 114.2 (2C), 122.0, 123.8, 
127.2 (2C), 127.4, 127.9, 144.3, 159.1. 
The spectral data were found identical to those previously de-
scribed.42 
Methyl 4-(2-thienyl)benzoate (1c) was prepared from thiophene 
(0.32 mL) using BuLi at –75 °C and methyl 4-bromobenzoate 
(0.86 g). 
Eluent: heptane/CH2Cl2 100/0 to 80/20. 
Yield: 41% (0.36 g). 
White powder. 
Mp 134 °C. 
1H NMR (300 MHz, CDCl3):  3.94 (s, 3H), 7.12 (dd, 1H, J = 4.9, 
3.6 Hz), 7.36 (dd, 1H, J = 5.1, 1.1 Hz), 7.42 (dd, 1H, J = 3.6, 1.3 
Hz), 7.67 (d, 2H, J = 8.8 Hz), 8.04 (d, 2H, J = 8.8 Hz). 
13C NMR (75 MHz, CDCl3):  53.8, 124.4, 125.5 (2C), 126.2, 
128.4, 129.1, 130.2 (2C), 138.5, 143.1, 166.7. 
The spectral data were found identical to those previously de-
scribed.43 
2-(4-Cyanophenyl)thiophene (1d) was prepared from thiophene 
(0.32 mL) using BuLi at –75 °C and 4-bromobenzonitrile (0.73 g). 
Eluent: heptane/CH2Cl2 100/0 to 80/20. 
Yield: 79% (0.54 g). 
White powder. 
Mp 88 °C. 
1H NMR (200 MHz, CDCl3):  7.13 (dd, 1H, J = 4.9, 3.7 Hz), 
7.40 (dd, 1H, J = 5.1, 1.2 Hz), 7.43 (dd, 1H, J = 3.7, 1.2 Hz), 7.66 
(d, 2H, J = 8.8 Hz), 7.70 (d, 2H, J = 8.5 Hz). 
13C NMR (50 MHz, CDCl3):  110.3, 118.7, 125.0, 125.9, 127.0, 
128.4 (2C), 132.6 (2C), 138.5, 141.9. 
The spectral data were found identical to those previously de-
scribed.44 
N-Boc 2-(4-methoxycarbonylphenyl)indole (2a)45 was prepared 
from N-Boc indole (0.81 mL) using LiTMP at –90 °C and methyl 
4-bromobenzoate (0.86 g). 
Eluent: heptane/CH2Cl2 70/30. 
Yield: 48% (0.68 g). 
White powder. 
Mp 190 °C. 
1H NMR (300 MHz, (CD3)2CO):  1.29 (s, 9H), 3.92 (s, 3H), 6.68 
(s, 1H), 7.16-7.41 (m, 2H), 7.49-7.62 (m, 3H), 8.08 (m, 2H), 8.26 
(d, 1H, J = 7.5 Hz). 
13C NMR (75 MHz, (CD3)2CO):  28.6 (3C), 53.3, 85.3, 112.5, 
116.8, 122.6, 124.8, 126.4, 130.5 (2C), 130.7 (2C), 130.9 (2C), 
139.5, 141.0, 141.1, 151.4, 167.8. 
Anal. Calcd for C21H21NO4 (351.40): C, 71.78; H, 6.02; N, 3.99. 
Found: C, 71.96; H, 6.14; N, 4.13%. 
N-Boc 2-(4-cyanophenyl)indole (2b) was prepared from N-Boc 
indole (0.81 mL) using LiTMP at –90 °C and 4-bromobenzonitrile 
(0.73 g). 
Eluent: heptane/CH2Cl2 70/30. 
Yield: 61% (0.78 g). 
White powder. 
Mp 121 °C. 
1H NMR (300 MHz, (CD3)2CO):  1.35 (s, 9H), 6.80 (s, 1H), 
7.22-7.44 (m, 2H), 7.64 (dd, 1H, J = 7.5, 1.1 Hz), 7.72 (m, 2H), 
7.88 (m, 2H), 8.22 (d, 1H, J = 8.5 Hz). 
These data were found identical to those previously described.46 
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13C NMR (75 MHz, (CD3)2CO):  28.7 (3C), 85.8, 112.8, 113.1, 
117.0, 117.6, 122.8, 125.1, 126.8, 131.0, 131.4 (2C), 133.6 (2C), 
139.6, 140.5, 141.3, 151.5. 
HRMS: calcd for C20H18N2O2 (M
+) 318.1368, found 318.1391. 
Anal. Calcd for C20H18N2O2 (318.37): C, 75.45; H, 5.70; N, 8.80. 
Found: C, 75.46; H, 5.80; N, 8.72%. 
N-Boc 2-(4-trifluoromethylphenyl)indole (2c) was prepared 
from N-Boc indole (0.81 mL) using LiTMP at –90 °C and 1-
bromo-4-(trifluoromethyl)benzene (0.55 mL). 
Eluent: heptane/toluene 80/20 to 40/60. 
Yield: 60% (0.86 g). 
White powder. 
Mp 104 °C. 
1H NMR (300 MHz, (CD3)2CO):  1.34 (s, 9H), 6.62 (s, 1H), 7.29 
(dd, 1H, J = 7.5, 1.5 Hz), 7.37 (ddd, 1H, J = 8.3, 7.5, 1.5 Hz), 
7.51-7.61 (m, 3H), 7.67 (d, 2H, J = 8.3 Hz), 8.21 (d, 1H, J = 8.3 
Hz). 
13C NMR (75 MHz, (CD3)2CO):  27.6 (3C), 83.9, 111.0, 115.3, 
120.7, 123.2, 124.2 (q, J = 272 Hz), 124.7, 124.8 (2C), 128.9 (2C), 
129.0, 129.6 (q, J = 32 Hz), 137.5, 138.5, 138.8, 149.9. 
These data were found identical to those previously described.47 
N-Boc 5-fluoro-2-(4-trifluoromethylphenyl)indole (3) was 
prepared from N-Boc 5-fluoroindole (0.59 g) using LiTMP at –90 
°C and 1-bromo-4-(trifluoromethyl)benzene (0.34 mL). 
Eluent: heptane/CH2Cl2 100/0 to 70/30. 
Yield: 36% (0.34 g). 
Yellow powder. 
Mp 117 °C. 
1H NMR (300 MHz, (CD3)2CO):  1.32 (s, 9H), 6.75 (s, 1H), 7.16 
(ddd, 1H, J = 9.0, 8.3, 3.0 Hz), 7.35 (dd, 1H, J = 8.3, 3.0 Hz), 7.72 
(d, 2H, J = 8.3 Hz), 7.82 (d, 2H, J = 8.3 Hz), 8.22 (dd, 1H, J = 9.0, 
3.0 Hz). 
13C NMR (75 MHz, (CD3)2CO):  28.6 (3C), 85.9, 107.9 (d, J = 
24 Hz), 112.2 (d, J = 4.4 Hz), 114.1 (d, J = 25 Hz), 118.3 (d, J = 
9.9 Hz), 126.6 (2C), 128.1 (q, J = 214 Hz), 131.1 (q, J = 31 Hz), 
131.3 (2C), 131.9 (d, J = 11 Hz), 135.9, 140.5, 142.4, 151.3, 161.2 
(d, J = 238 Hz). 
HRMS: calcd for C20H17F4NO2 (M
+) 379.1195, found 379.1183. 
N-Boc 5-bromo-2-(4-methoxycarbonylphenyl)indole (4a) was 
prepared from N-Boc 5-bromoindole (1.2 g) using LiTMP at –90 
°C and methyl 4-bromobenzoate (0.86 g). 
Eluent: heptane/CH2Cl2 50/50 to 40/60. 
Yield: 66% (1.1 g). 
Beige powder. 
Mp 154 °C. 
1H NMR (300 MHz, (CD3)2CO):  1.31 (s, 9H), 3.92 (s, 3H), 6.74 
(s, 1H), 7.49 (dd, 1H, J = 8.5, 2.0 Hz), 7.65 (d, 2H, J = 8.6 Hz), 
7.81 (d, 1H, J = 2.0 Hz), 8.10 (d, 2H, J = 8.6 Hz), 8.15 (d, 1H, J = 
8.5 Hz). 
13C NMR (75 MHz, (CD3)2CO):  28.6 (3C), 53.4, 86.1, 111.5, 
117.6, 118.7, 125.1, 129.1, 130.7 (2C), 130.9, 131.4 (2C), 132.8, 
138.3, 140.7, 142.5, 151.2, 167.9. 
HRMS: calcd for C21H20
79BrNO4 (M
+) 429.0576, found 429.0543. 
Anal. Calcd for C21H20BrNO4 (430.29): C, 58.62; H, 4.69; N, 
3.26. Found: C, 58.59; H, 4.89; N, 3.29%. 
N-Boc 5-bromo-2-(4-trifluoromethylphenyl)indole (4b) was 
prepared from N-Boc 5-bromoindole (1.2 g) using LiTMP at –90 
°C and 1-bromo-4-(trifluoromethyl)benzene (0.54 mL). 
Eluent: heptane/CH2Cl2 100/0 to 60/40. 
Yield: 31% (0.54 g). 
White powder. 
Mp 104 °C. 
1H NMR (300 MHz, (CD3)2CO):  1.31 (s, 9H), 6.70 (s, 1H), 7.46 
(dd, 1H, J = 9.1, 2.0 Hz), 7.59-7.85 (m, 5H), 8.15 (d, 1H, J = 9.1 
Hz). 
13C NMR (75 MHz, (CD3)2CO):  28.5 (3C), 86.0, 111.6, 117.7, 
118.7, 125.1, 125.8 (q, J = 271 Hz), 126.6 (q, 2C, J = 3.9 Hz), 
129.1, 130.6 (q, J = 32 Hz), 131.3 (2C), 132.7, 138.1, 140.1 (q, J = 
1.6 Hz), 141.9, 151.1. 
HRMS: calcd for C20H17
79BrF3NO2 (M
+) 439.0394, found 
439.0401. 
4-(2-Benzo[b]furyl)-2-chloropyrimidine (5a) was prepared from 
benzo[b]furan (0.44 mL) using BuLi at –15 °C and 2,4-
dichloropyrimidine (0.60 g). 
Eluent: CH2Cl2/MeOH 100/0 to 80/20. 
Yield: 56% (0.52 g). 
Pale yellow powder. 
Mp 186 °C. 
1H NMR (200 MHz, (CD3)2CO):  7.37 (t, 1H, J = 7.8 Hz), 7.51 
(t, 1H, J = 7.8 Hz), 7.69 (d, 1H, J = 7.8 Hz), 7.82 (d, 1H, J = 7.8 
Hz), 7.90 (s, 1H), 7.97 (d, 1H, J = 5.2 Hz), 8.86 (d, 1H, J = 5.2 
Hz). 
The 1H NMR spectrum was found identical to that previously 
described.23 
13C NMR (50 MHz, (CD3)2CO):  110.9, 112.4, 114.5, 123.5, 
124.7, 127.8, 128.5, 152.2, 156.5, 158.6, 161.8, 162.1. 
HRMS: calcd for C12H7
35ClN2O (M
+) 230.0247, found 230.0238. 
Anal. Calcd for C12H7ClN2O (230.65): C, 62.49; H, 3.06; N, 
12.15. Found: C, 62.75; H, 3.13; N, 12.35%. 
2-Chloro-4-(2-furyl)pyrimidine (6) was prepared from furan 
(0.29 mL) using BuLi at –15 °C and 2,4-dichloropyrimidine (0.60 
g). 
Eluent: heptane/EtOAc 100/0 to 80/20. 
Yield: 61% (0.45 g). 
White powder. 
Mp 88 °C. 
1H NMR (200 MHz, CDCl3):  6.60 (dd, 1H, J = 3.5, 1.5 Hz), 
7.38 (dd, 1H, J = 3.5, 1.0 Hz), 7.51 (d, 1H, J = 5.2 Hz), 7.63 (m, 
1H), 8.57 (d, 1H, J = 5.2 Hz). 
The 1H NMR spectrum was found identical to that previously 
described.23 
13C NMR (50 MHz, CDCl3):  113.1, 113.1, 114.5, 146.2, 150.4, 
158.1, 159.9, 161.7. 
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4-(2-Benzo[b]thienyl)-2-chloropyrimidine (7a) was prepared 
from benzo[b]thiophene (0.54 g) using BuLi at –75 °C and 2,4-
dichloropyrimidine (0.60 g). 
Eluent: heptane/EtOAc 100/0 to 70/30. 
Yield: 29% (0.29 g). 
Pale yellow powder. 
Mp 198 °C. 
1H NMR (200 MHz, CDCl3):  7.38-7.46 (m, 2H), 7.59 (d, 1H, J 
= 5.5 Hz), 7.82-7.92 (m, 2H), 8.12 (s, 1H), 8.60 (d, 1H, J = 5.5 
Hz). 
The 1H NMR spectrum was found identical to that previously 
described.23 
13C NMR (50 MHz, CDCl3):  114.5, 122.9, 125.2, 125.3, 126.3, 
126.9, 139.8, 140.1, 141.8, 159.7, 161.9, 162.3. 
2-(2-Benzo[b]thienyl)pyridine (7b) was prepared from 
benzo[b]thiophene (0.54 g) using BuLi at –75 °C and 2-
chloropyridine (0.38 mL). 
Eluent: heptane/CH2Cl2 50/50 to 30/70. 
Yield: 81% (0.69 g). 
White powder. 
Mp 126 °C. 
1H NMR (200 MHz, CDCl3):  7.21 (m, 1H), 7.36 (m, 2H), 7.73 
(dt, 1H, J = 8.0, 1.6 Hz), 7.81 (m, 4H), 8.64 (d, 1H, J = 5.0 Hz). 
13C NMR (50 MHz, CDCl3):  119.6, 121.1, 122,6 (2C), 124.1, 
124.5, 125.0, 136.6, 140.5, 140.6, 144.8, 149.7, 152.5. 
The spectral data were found identical to those of a commercial 
sample. 
HRMS: calcd for C13H9NS (M
+) 211.0456, found 211.0461. 
2-Chloro-4-(2-thienyl)pyrimidine (1e) was prepared from thio-
phene (0.32 mL) using BuLi at –75 °C and 2,4-dichloropyrimidine 
(0.60 g). 
Eluent: heptane/EtOAc 100/0 to 80/20. 
Yield: 56% (0.44 g). 
White powder. 
Mp 124 °C. 
The physical data were found identical to those previously de-
scribed.48 
1H NMR (200 MHz, (CD3)2CO):  7.17 (dd, 1H, J = 7.5, 5.7 Hz), 
7.46 (d, 1H, J = 7.8 Hz), 7.59 (dd, 1H, J = 7.5, 1.5 Hz), 7.82 (dd, 
1H, J = 5.7, 1.5 Hz), 8.53 (d, 1H, J = 8.1 Hz). 
13C NMR (50 MHz, (CD3)2CO):  113.7, 128.8, 129.2, 131.8, 
140.5, 159.5, 161.7, 162.0. 
2-(5-Chlorothienyl)pyridine (8) was prepared from 2-
chlorothiophene (0.37 mL) using BuLi at –75 °C and 2-
chloropyridine (0.38 mL). 
Eluent: heptane/EtOAc 100/0 to 80/20. 
Yield: 85% (0.67 g). 
Pale yellow powder. 
Mp 67 °C. 
1H NMR (200 MHz, CDCl3):  6.91 (d, 1H, J = 3.8 Hz), 7.15 
(ddd, 1H, J = 7.1, 4.9, 1.5 Hz), 7.33 (d, 1H, J = 3.8 Hz), 7.56 (dt, 
1H, J = 8.1, 1.0 Hz), 7.66 (ddd, 1H, J = 9.1, 7.6, 2.0 Hz), 8.53 (dq, 
1H, J = 4.9, 1.0 Hz). 
13C NMR (50 MHz, CDCl3):  117.2, 121.5, 122.9 (CH), 126.7, 
131.4, 135.9, 143.0, 148.7, 150.8. 
The spectral data were found identical to those previously de-
scribed.49 
N-Boc 2-(2-chloro-4-pyrimidyl)indole (9a) was prepared from 
N-Boc indole (0.82 mL) using LiTMP at –75 °C and 2,4-
dichloropyrimidine (0.60 g). 
Eluent: hexane/CH2Cl2 70/30 to 30/70. 
Yield: 25% (0.33 g). 
Beige powder. 
Mp 114 °C. 
1H NMR (400 MHz, CDCl3):  1.47 (s, 9H), 7.02 (d, 1H,
 J = 0.9 
Hz), 7.28 (ddd, 1H, J = 7.9, 7.0, 0.9 Hz), 7.43 (ddd, 1H, J = 8.3, 
7.0, 1.3 Hz), 7.45 (d, 1H, J = 5.3 Hz), 7.62 (ddd, 1H, J = 7.9, 1.3, 
0.9 Hz), 8.17 (dd, 1H, J = 8.3, 0.9 Hz), 8.64 (d, 1H, J = 5.3 Hz). 
13C NMR (100 MHz, CDCl3):  27.9 (3C), 84.9, 115.1, 115.4, 
117.9, 122.0, 123.7, 126.9, 128.4, 135.6, 138.9, 149.7, 159.4, 
161.1, 163.0. 
Anal. Calcd for C17H16ClN3O2 (329.78): C, 61.91; H, 4.89; N, 
12.74. Found: C, 61.90; H, 4.86; N, 12.69%. 
N-Boc 2-(2-pyridyl)pyrrole (9b) was prepared from N-Boc pyr-
role (0.67 mL) using LiTMP at –75 °C and 2-chloropyridine (0.38 
mL). 
Eluent: heptane/CH2Cl2 70/30 to 0/100. 
Yield: 61% (0.60 g). 
Yellow oil. 
1H NMR (200 MHz, CDCl3):  1.31 (s, 9H), 6.18 (t, 1H, J = 3.2 
Hz), 6.36 (dd, 1H, J = 3.5, 1.5 Hz), 7.07-7.19 (m, 1H), 7.29-7.39 
(m, 2H), 7.61 (ddd, 1H, J = 9.6, 7.5, 1.5 Hz), 8.56 (d, 1H, J = 4.5 
Hz). 
The spectral data were found identical to those previously de-
scribed.50 
N-Boc 2-(2-chloro-4-pyrimidyl)pyrrole (2d) was prepared from 
N-Boc pyrrole (0.67 mL) using LiTMP at –90 °C and 2,4-
dichloropyrimidine (0.60 g). 
Eluent: heptane/CH2Cl2 50/50 to 0/100. 
Yield: 25% (0.26 g). 
Beige powder. 
Mp 102 °C. 
1H NMR (200 MHz, CDCl3):  1.45 (s, 9H), 6.25 (t, 1H,
 J = 3.5 
Hz), 6.69 (dd, 1H, J = 3.5, 2.0 Hz), 7.31 (d, 1H, J = 5.5 Hz), 7.41 
(dd, 1H, J = 3.5, 2.0 Hz), 8.51 (d, 1H, J = 5.5 Hz). 
13C NMR (50 MHz, CDCl3):  27.7 (3C), 85.1, 111.4, 117.6, 
120.0, 127.1, 130.5, 148.8, 158.9, 160.7, 161.9. 
HRMS: calcd for C13H14
35ClN3O2 (M
+) 279.0774, found 
279.0787. 
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N-Boc 2-(2-pyridyl)indole (2e)51 was prepared from N-Boc in-
dole (0.81 mL) using LiTMP at –90 °C and 2-chloropyridine (0.38 
mL). 
Eluent: heptane/CH2Cl2 60/40 to 0/100. 
Yield: 27% (0.32 g). 
Brown oil. 
1H NMR (300 MHz, CDCl3):  1.33 (s, 9H), 6.77 (s, 1H), 7.22-
7.29 (m, 2H), 7.36 (ddd, 1H, J = 8.3, 6.8, 1.5 Hz), 7.51 (dt, 1H, J 
= 7.5, 1.5 Hz), 7.59 (d, 1H, J = 8.3 Hz), 7.74 (ddd, 1H, J = 8.3, 
7.5, 1.5 Hz), 8.19 (d, 1H, J = 7.5 Hz), 8.67 (d, 1H, J = 6.8 Hz). 
13C NMR (75 MHz, CDCl3):  27.6 (3C), 83.4, 111.0, 115.0, 
120.9, 122.2, 122.9, 123.3, 124.9, 128.8, 136.0, 137.7, 139.3, 
148.9, 150.0, 153.3. 
HRMS: calcd for C18H18N2O2 (M
+) 294.1368, found 294.1352. 
Anal. Calcd for C18H18N2O2 (294.35): C, 73.45; H, 6.16; N, 9.52. 
Found: C, 73.14; H, 6.05; N, 9.30%. 
N-Boc 2-(2-chloro-4-pyrimidyl)-4-methoxyindole (10) was 
prepared from N-Boc 4-methoxyindole (1.0 g) using LiTMP at 
–90 °C and 2,4-dichloropyrimidine (0.60 g). 
Eluent: hexane/CH2Cl2 40/60 to 0/100. 
Yield: 18% (0.26 g). 
Yellow powder. 
Mp 148 °C. 
1H NMR (400 MHz, CDCl3):  1.46 (s, 9H), 3.95 (s, 3H), 6.69 (d, 
1H, J = 7.9 Hz), 7.16 (s, 1H), 7.34 (dd, 1H, J = 8.3, 7.9 Hz), 7.44 
(d, 1H, J = 5.3 Hz), 7.74 (d, 1H, J = 8.3 Hz), 8.61 (d, 1H, J = 5.3 
Hz). 
13C NMR (100 MHz, CDCl3):  27.9 (3C), 55.7, 84.8, 103.5, 
108.1, 112.5, 117.6, 119.2, 128.0, 134.1, 140.3, 149.8, 153.9, 
159.3, 161.1, 162.9. 
ESCI MS: m/z 303.79, 305.74 [M+H-tBu]+; 259.80, 261.73 
[M+H-Boc]+. 
N-Boc 4-bromo-2-(2-chloro-4-pyrimidyl)indole (11) was 
prepared from N-Boc 4-bromoindole (1.2 g) using LiTMP at –90 
°C and 2,4-dichloropyrimidine (0.60 g). 
Eluent: hexane/CH2Cl2 40/60 to 0/100. 
Yield: 17% (0.28 g). 
Beige powder. 
Mp 125-126 °C. 
1H NMR (400 MHz, CDCl3):  1.45 (s, 9H), 7.06 (d, 1H, J = 0.9 
Hz), 7.29 (dd, 1H, J = 8.3, 7.9 Hz), 7.45 (dd, 1H, J = 7.9, 0.9 Hz), 
7.50 (d, 1H, J = 4.8 Hz), 8.12 (ddd, 1H, J = 8.3, 1.2, 0.9 Hz), 8.68 
(d, 1H, J = 4.8 Hz). 
13C NMR (100 MHz, CDCl3):  27.8 (3C), 85.4, 114.3, 114.5, 
115.7, 118.0, 126.5, 127.6, 129.2, 136.0, 139.0, 149.3, 159.7, 
161.2, 162.6. 
ESCI MS: m/z 353.76, 355.79 [M+H-tBu]+; 307.85, 309.82 
[M+H-Boc]+. 
N-Boc 2-(2-chloro-4-pyrimidyl)-5-cyanoindole (12) was 
prepared from N-Boc 5-cyanoindole (0.97 g) using LiTMP at –90 
°C and 2,4-dichloropyrimidine (0.60 g). 
Eluent: hexane/CH2Cl2 50/50 to 0/100. 
Yield: 21% (0.29 g). 
Yellow oil. 
1H NMR (400 MHz, CDCl3):  1.42 (s, 9H), 6.98 (s, 1H), 7.50 (d, 
1H, J = 4.8 Hz), 7.60 (dd, 1H, J = 8.7, 1.7 Hz), 7.91 (dd, 1H, J = 
1.7, 0.9 Hz), 8.21 (d, 1H, J = 8.7 Hz), 8.69 (d, 1H, J = 4.8 Hz). 
13C NMR (100 MHz, CDCl3):  27.6 (3C), 85.9, 106.9, 113.3, 
116.2, 118.0, 119.4, 126.7, 128.1, 129.2, 137.4, 140.0, 148.6, 
159.9, 161.0, 162.0. 
ESCI MS: m/z 298.88, 300.88 [M+H-tBu]+; 254.87, 256.86 
[M+H-Boc]+. 
N-Boc 2-(2-chloro-4-pyrimidyl)-5-nitroindole (13) was prepared 
from N-Boc 5-nitroindole (1.05 g) using LiTMP at –90 °C and 
2,4-dichloropyrimidine (0.60 g). 
Eluent: hexane/CH2Cl2 50/50 to 0/100. 
Yield: 20% (0.30 g). 
Yellow powder. 
Mp > 260 °C. 
1H NMR (400 MHz, CDCl3):  1.46 (s, 9H), 7.09 (s, 1H), 7.51 (d, 
1H, J = 5.3 Hz), 8.29-8.31 (m, 2H), 8.56 (dd, 1H, J = 1.7, 0.9 Hz), 
8.73 (d, 1H, J = 5.3 Hz). 
13C NMR (100 MHz, CDCl3):  27.8 (3C), 86.4, 114.2, 115.8, 
118.1, 118.3, 121.7, 128.0, 138.5, 141.1, 144.4, 148.8, 160.1, 
161.3, 162.1. 
ESCI MS: m/z 318.73, 320.73 [M+H-tBu]+; 274.78, 276.71 
[M+H-Boc]+. 
2-(2-Methoxyphenyl)pyridine (14) was prepared from anisole 
(0.44 mL) using BuLi at 25 °C and 2-chloropyridine (0.38 mL). 
Eluent: CH2Cl2. 
Yield: 64% (0.43 g). 
Colourless oil. 
1H NMR (200 MHz, CDCl3):  3.87 (s, 3H), 7.02 (d, 1H, J = 8.3 
Hz), 7.09 (t, 1H, J = 7.5 Hz), 7.2 (m, 1H), 7.37 (dt, 1H, J = 7.8, 
1.7 Hz), 7.7 (m, 3H), 8.71 (dd, 1H, J = 4.3, 1.2 Hz). 
13C NMR (50 MHz, CDCl3):  56.0, 111.7, 121.4, 122.0, 125.5, 
129.5, 130.3, 131.5, 136.0, 149.8, 156.4, 157.2. 
The spectral data were found identical to those previously de-
scribed.52 
2-Fluoro-3-(2-pyridyl)pyridine (15) was prepared from 2-
fluoropyridine (0.34 mL) using LiTMP at –75 °C and 2-
chloropyridine (0.38 mL). 
Eluent: heptane/CH2Cl2 60/40 to 0/100. 
Yield: 62% (0.43 g). 
Beige powder. 
Mp < 50 °C. 
1H NMR (200 MHz, CDCl3):  7.25-7.37 (m, 2H), 7.72-7.91 (m, 
2H), 8.25 (d, 1H, J = 3.2 Hz), 8.47-8.58 (m, 1H), 8.72 (d, 1H, J = 
4.8 Hz). 
13C NMR (50 MHz, CDCl3):  122.1 (d, J = 4.3 Hz), 122.6, 123.2, 
124.3 (d, J = 10 Hz), 136.8, 141.6 (d, J = 3.8 Hz), 147.7 (d, J = 15 
Hz), 150.0, 151.4 (d, J = 6.8 Hz), 160.9 (d, J = 241 Hz). 
HRMS: calcd for C10H7FN2 (M
+) 174.0593, found 174.0595. 
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General Procedure for the Deprotonation/Cross-coupling 
Sequence (Compounds 1b and 5b). 
To a stirred and cooled solution (temperature given in the product 
description) of the appropriate reagent (4.0 mmol) in dry THF (5 
mL) under argon were added the required base (4.0 mmol) and, 1 
h later, ZnCl2·TMEDA
34 (0.33 g, 1.3 mmol). The mixture was 
slowly warmed to r.t. (1 h) before addition of the appropriate 
aromatic halide (4.0 mmol), PdCl2 (14 mg, 80 mol), dppf (44 
mg, 80 mol) and 1,2-dimethoxyethane (2.1 mL, 20 mmol), and 
heated at 55 °C for 12 h. The mixture was cooled before addition 
of water (0.5 mL). Extraction with EtOAc (2 x 25 mL), drying 
over Na2SO4, and removal of the solvents under reduced pressure 
afforded a crude compound which was purified by chromatog-
raphy on silica gel (the eluent is given in the product description). 
2-(4-Nitrophenyl)thiophene (1b) was prepared from thiophene 
(0.32 mL) using BuLi at –75 °C and 1-bromo-4-nitrobenzene 
(0.81 g). 
Eluent: heptane/EtOAc 100/0 to 90/10. 
Yield: 76% (0.62 g). 
Yellow powder. 
Mp 135 °C. 
1H NMR (200 MHz, CDCl3):  7.15 (t, 1H, J = 4.4 Hz), 7.44 (d, 
1H, J = 5.2 Hz), 7.48 (d, 1H, J = 4.0 Hz), 7.74 (d, 2H, J = 9.5 Hz), 
8.23 (d, 2H, J = 8.8 Hz). 
13C NMR (50 MHz, CDCl3):  124.4, 125.7 (2C), 126.0, 127.7, 
128.7 (2C), 140.6, 141.6, 146.6. 
The spectral data were found identical to those previously de-
scribed.53 
2-(2-Benzo[b]furyl)pyridine (5b) was prepared from ben-
zo[b]furan (0.44 mL) using butyllithium at –15 °C and 2-
chloropyridine (0.38 mL). 
Eluent: heptane/CH2Cl2 60/40. 
Yield: 76% (0.60 g). 
White powder. 
Mp 88 °C. 
1H NMR (200 MHz, CDCl3):  7.20-7.39 (m, 3H), 7.43 (d, 1H, J 
= 1.0 Hz), 7.57 (dq, 1H, J = 8.1, 1.0 Hz), 7.62-7.68 (m, 1H), 7.78 
(ddd, 1H, J = 9.3, 8.1, 1.5 Hz), 7.91 (dt, 1H, J = 9.3, 1.0 Hz), 8.69 
(m, 1H). 
The spectral data were found identical to those previously de-
scribed.54 
General Procedure for the Substitution of the Chloro Group of 
Compounds 2d, 9a, 5a, 6, 7a and 1e with Allylamine and Sub-
sequent Allyl Cleavage (Compounds 16-21). 
A stirred solution of the aromatic chloride (1.0 mmol) in 
allylamine (5 mL) was heated under reflux for 2 h. After 
concentration under reduced pressure, water (10 mL) and aq 1M 
NaOH (1 mL) were added before extraction with EtOAc (3 x 15 
mL). The combined organic phases were washed with brine (10 
mL), dried over Na2SO4, and the solvents were removed under 
reduced pressure. After checking the purity by NMR, the crude 
allylated compound was directly dissolved in EtOH (5 mL), and 
MeSO3H (85 μL, 1.3 mmol) and palladium on charcoal (10%, 
0.10 g) were added at r.t. The mixture was then heated under 
reflux for 3 days, filtrated over celite
®
, and the solvents were 
removed under reduced pressure. An aq sat. NaHCO3 solution (10 
mL) was added to the residue before extraction with EtOAc (3 x 
15 mL). The combined organic phases were washed with brine (10 
mL), and dried over Na2SO4. The solvent was removed under 
reduced pressure before purification by chromatography on silica 
gel (eluent given in the product description). 
4-(2-Indolyl)-2-pyrimidinamine (16, Isomeridianin G). Precur-
sor N-allyl-4-(2-indolyl)-2-pyrimidinamine was prepared from N-
Boc 2-(2-chloro-4-pyrimidyl)indole (2d, 0.33 g), and identified by 
NMR: 
1H NMR (200 MHz, CDCl3):  4.14-4.22 (m, 2H), 5.19 (dq, 1H, J 
= 11, 1.5 Hz), 5.26 (s, 1H), 5.31 (dq, 1H, J = 17, 1.5 Hz), 5.96-
6.11 (m, 1H), 7.00 (d, 1H, J = 5.3 Hz), 7.09-7.16 (m, 2H), 7.27 
(ddd, 1H, J = 8.3, 7.0, 1.5 Hz), 7.44 (d, 1H, J = 8.3 Hz), 7.66 (d, 
1H, J = 7.5 Hz), 8.29 (d, 1H, J = 5.3 Hz), 9.36 (s, 1H). 
13C NMR (50 MHz, CDCl3):  44.0, 103.6, 106.1, 111.5, 115.8, 
120.4, 121.6 (2C), 128.7, 135.0, 135.1, 136.5, 157.4, 158.1, 162.1. 
4-(2-Indolyl)-2-pyrimidinamine (16, Isomeridianin G): 
Eluent: EtOAc/CH2Cl2 70/30. 
Yield: 48% (2 steps, 0.10 g). 
Yellow powder. 
Mp 225 °C. 
1H NMR (300 MHz, CDCl3):  5.07 (s, 2H), 7.07 (d, 1H, J = 5.3 
Hz), 7.09-7.16 (m, 2H), 7.27 (td, 1H, J = 8.3, 1.5 Hz), 7.43 (d, 1H, 
J = 8.3 Hz), 7.66 (d, 1H, J = 8.3 Hz), 8.28 (d, 1H, J = 5.3 Hz), 
9.40 (s, 1H). 
13C NMR (75 MHz, CDCl3):  104.2, 106.9, 111.6, 120.5, 121.7, 
124.5, 128.6, 134.2, 136.7, 157.5, 158.0, 162.9. 
HRMS: calcd for C12H10N4 (M
+) 210.0905, found 210.0884. 
The physical and spectral data were found identical to those previ-
ously described.31 
4-(2-Pyrryl)-2-pyrimidinamine (17).55 Precursor N-allyl-4-(2-
pyrryl)-2-pyrimidinamine was prepared from N-Boc 2-(2-chloro-
4-pyrimidyl)pyrrole (9a, 0.28 g), and identified by NMR: 
1H NMR (200 MHz, CDCl3):  4.06-4.16 (m, 2H), 5.15 (dq, 1H, J 
= 10, 1.5 Hz), 5.27 (dq, 1H, J = 17, 1.5 Hz), 5.30 (s, 1H), 5.87-
6.10 (m, 1H), 6.30 (m, 1H), 6.76 (d, 1H, J = 5.1 Hz), 6.81 (ddd, 
1H, J = 3.5, 2.5, 1.2 Hz), 6.96 (ddd, 1H, J = 3.5, 2.5, 1.2 Hz), 8.18 
(d, 1H, J = 5.1 Hz), 9.55 (s, 1H). 
13C NMR (50 MHz, CDCl3):  43.9, 104.6, 110.3, 110.8, 115.6, 
121.1, 129.7, 135.2, 157.0, 157.6, 161.8. 
4-(2-Pyrryl)-2-pyrimidinamine (17): 
Eluent: EtOAc/CH2Cl2 50/50. 
Yield: 70% (2 steps, 0.11 g). 
Beige powder. 
Mp 183 °C. 
1H NMR (300 MHz, (CD3)2CO):  5.80 (s, 2H), 6.18-6.24 (m, 
1H), 6.88 (d, 1H, J = 5.1 Hz), 6.84-6.89 (m, 1H), 6.97-7.01 (m, 
1H), 8.13 (d, 1H, J = 5.1 Hz), 10.6 (s, 1H). 
13C NMR (75 MHz, (CD3)2CO):  106.6, 112.3, 112.7, 124.1, 
132.5, 159.8, 160.9, 165.8. 
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HRMS: calcd for C8H8N4 (M
+) 160.0749, found 160.0743. 
4-(2-Benzo[b]furyl)-2-pyrimidinamine (18). Precursor N-allyl-4-
(2-benzo[b]furyl)-2-pyrimidinamine was prepared from 4-(2-
benzo[b]furyl)-2-chloropyrimidine (5a, 0.23 g), and identified by 
NMR: 
1H NMR (200 MHz, CDCl3):  4.11-4.20 (m, 2H), 5.17 (dq, 1H, J 
= 11, 1.5 Hz), 5.30 (dq, 1H, J = 17, 1.5 Hz), 5.35 (s, 1H), 5.90-
6.12 (m, 1H), 7.10 (d, 1H, J = 5.1 Hz), 7.26 (ddd, 1H, J = 8.6, 7.6, 
1.0 Hz), 7.37 (ddd, 1H, J = 8.6, 7.0, 1.5 Hz), 7.52 (s, 1H), 7.56 (d, 
1H, J = 7.0 Hz), 7.66 (dd, 1H, J = 7.6, 1.5 Hz), 8.40 (d, 1H, J = 
5.1 Hz). 
13C NMR (50 MHz, CDCl3):  43.8, 105.9, 107.4, 111.7, 115.7, 




Yield: 55% (2 steps, 0.12 g). 
Pale yellow powder. 
Mp 205 °C. 
1H NMR (300 MHz, CDCl3):  5.24 (s, 2H), 7.17 (d, 1H, J = 5.3 
Hz), 7.29 (t, 1H, J = 7.5 Hz), 7.39 (ddd, 1H, J = 8.5, 7.5, 1.5 Hz), 
7.53 (s, 1H), 7.58 (d, 1H, J = 8.5 Hz), 7.66 (d, 1H, J = 7.6 Hz), 
8.39 (d, 1H, J = 5.3 Hz). 
13C NMR (75 MHz, CDCl3):  106.9, 108.0, 111.8, 122.1, 123.5, 
126.3, 128.2, 152.7, 155.1, 156.3, 158.9, 162.5. 
HRMS: calcd for C12H9N3O (M
+) 211.0746, found 211.0745. 
4-(2-Furyl)-2-pyrimidinamine (19).55 Precursor N-allyl-4-(2-
furyl)-2-pyrimidinamine was prepared from 4-(2-furyl)-2-
chloropyrimidine (6, 0.18 g) , and identified by NMR: 
1H NMR (200 MHz, CDCl3):  4.07-4.17 (m, 2H), 5.15 (dq, 1H, J 
= 11, 1.5 Hz), 5.28 (dq, 1H, J = 17, 1.5 Hz), 5.30 (s, 1H), 5.88-
6.10 (m, 1H), 6.54 (dd, 1H, J = 3.6, 1.5 Hz), 6.90 (d, 1H, J = 5.1 
Hz), 7.16 (d, 1H, J = 3.6 Hz), 7.57 (m, 1H), 8.31 (d, 1H, J = 5.1 
Hz). 
13C NMR (50 MHz, CDCl3):  43.8, 104.9, 111.5, 112.1, 115.7, 
135.0, 144.5, 152.2, 156.1, 158.5, 162.2. 
4-(2-Furyl)-2-pyrimidinamine (19): 
Eluent: EtOAc. 
Yield: 26% (2 steps, 42 mg). 
Dark yellow powder (degradation before melting). 
1H NMR (300 MHz, CDCl3):  5.15 (s, 2H), 6.54 (dd, 1H, J = 3.8, 
2.2 Hz), 6.96 (d, 1H, J = 5.1 Hz), 7.14 (d, 1H, J = 3.8 Hz), 7.57 (s, 
1H), 8.30 (d, 1H, J = 5.1 Hz). 
13C NMR (50 MHz, CDCl3):  104.7, 110.9, 111.3, 143.5, 152.5, 
156.2, 158.4, 162.6. 
HRMS: calcd for C8H7N3O (M
+) 161.0589, found 161.0577. 
4-(2-Benzo[b]thienyl)-2-pyrimidinamine (20). Precursor N-allyl-
4-(2-benzo[b]thienyl)-2-pyrimidinamine was prepared from 4-(2-
benzo[b]thienyl)-2-chloropyrimidine (7a, 0.22 g), and identified 
by NMR: 
1H NMR (200 MHz, CDCl3):  4.04-4.14 (m, 2H), 5.11 (dq, 1H, J 
= 11, 1.5 Hz), 5.26 (dq, 1H, J = 17, 1.5 Hz), 5.25 (s, 1H), 5.84-
6.06 (m, 1H), 6.95 (d, 1H, J = 5.1 Hz), 7.27-7.35 (m, 2H), 7.72-
7.84 (m, 2H), 7.88 (s, 1H), 8.25 (d, 1H, J = 5.1 Hz). 
13C NMR (50 MHz, CDCl3):  43.9, 105.7, 115.9, 122.6, 123.7, 
124.5, 124.6, 125.7 (2C), 134.9, 139.9, 140.9, 158.3, 159.8, 162.2. 
4-(2-Benzo[b]thienyl)-2-pyrimidinamine (20): 
Eluent: EtOAc. 
Yield: 58% (2 steps, 0.13 g). 
White powder. 
Mp 230 °C. 
1H NMR (300 MHz, CDCl3):  5.11 (s, 2H), 7.08 (d, 1H, J = 5.3 
Hz), 7.34-7.43 (m, 2H), 7.78-7.91 (m, 2H), 7.96 (s, 1H), 8.33 (d, 
1H, J = 5.3 Hz). 
13C NMR (75 MHz, CDCl3):  105.2, 123.5, 124.4, 124.5, 125.6 
(2C), 139.8, 140.8, 143.4, 158.2, 159.9, 162.3. 
HRMS: calcd for C12H9N3S (M
+) 227.0517, found 227.0531. 
4-(2-Thienyl)-2-pyrimidinamine (21). Precursor N-allyl-4-(2-
thienyl)-2-pyrimidinamine was prepared from 4-(2-thienyl)-2-
chloropyrimidine (1e, 0.20 g), and identified by NMR: 
1H NMR (200 MHz, CDCl3):  4.00-4.11 (m, 2H), 5.08 (dq, 1H, J 
= 10, 1.5 Hz), 5.22 (dq, 1H, J = 17, 1.5 Hz), 5.23 (s, 1H), 5.82-
6.03 (m, 1H), 6.86 (d, 1H, J = 5.1 Hz), 7.11 (dd, 1H, J = 5.0, 3.5 
Hz), 7.44 (dd, 1H, J = 5.0, 1.0 Hz), 7.66 (dd, 1H, J = 3.5, 1.0 Hz), 
8.27 (d, 1H, J = 5.1 Hz). 
13C NMR (50 MHz, CDCl3):  43.9, 104.6, 115.8, 126.9, 127.9, 
129.5, 134.7, 140.5, 158.6, 159.4, 162.6. 
4-(2-Thienyl)-2-pyrimidinamine (21): 
Eluent: EtOAc/CH2Cl2 50/50. 
Yield: 29% (2 steps, 51 mg). 
Pale yellow powder. 
Mp 181 °C (lit.56 174 °C). 
1H NMR (300 MHz, (CD3)2CO):  6.06 (s, 2H), 7.05 (d, 1H, J = 
5.3 Hz), 7.16 (dd, 1H, J = 5.3, 3.8 Hz), 7.63 (dd, 1H, J = 5.3, 1.5 
Hz), 7.83 (dd, 1H, J = 3.8, 1.5 Hz), 8.25 (d, 1H, J = 5.3 Hz). 
13C NMR (75 MHz, (CD3)2CO):  105.6, 127.9, 128.9, 130.2, 
144.2, 159.6, 160.4, 164.8. 
HRMS: calcd for C8H7N3S (M
+) 177.0361, found 177.0373. 
General Procedure for the Deprotection of N-Boc Indoles 
using TFA (Compounds 22, 23, 25-27). 
To a stirred solution of the appropriate N-Boc indole (2.0 mmol) in 
CH2Cl2 (10 mL) at r.t. was added TFA (30 mmol). After 2 h at r.t., 
a sat. aq NaHCO3 solution (10 mL) was added. Extraction with 
EtOAc (3 x 10 mL), washing with brine (10 mL), drying over 
Na2SO4, and removal of the solvents under reduced pressure 
afforded a crude product which was purified by chromatography 
on silica gel (eluent given in the product description). 
2-(4-Methoxycarbonylphenyl)indole (22) was prepared from N-
Boc 2-(4-methoxycarbonylphenyl)indole (2a, 0.71 g). 
Eluent: CH2Cl2. 
Yield: 52% (0.27 g). 
Yellow powder. 
Mp 200 °C. 
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1H NMR (300 MHz, CDCl3):  3.92 (s, 3H), 6.95 (dd, 1H, J = 2.5, 
1.0 Hz), 7.14 (ddd, 1H, J = 8.6, 7.5, 1.5 Hz), 7.24 (ddd, 1H, J = 
8.6, 8.0, 1.5 Hz), 7.42 (dd, 1H, J = 8.0, 1.5 Hz), 7.65 (d, 1H, J = 
7.5 Hz), 7.72 (dt, 2H, J = 8.6, 2.0 Hz), 8.10 (dt, 2H, J = 8.6, 2.0 
Hz), 8.47 (s, 1H). 
These spectral data were found identical to those previously de-
scribed.57 
13C NMR (75 MHz, CDCl3):  52.2, 101.8, 111.1, 120.6, 121.0, 
123.1, 124.6 (2C), 128.8, 129.0, 130.3 (2C), 136.4, 137.2, 141.3, 
166.7. 
HRMS: calcd for C16H13NO2 (M
+) 251.0946, found 251.0968. 
Anal. Calcd for C16H13NO2 (251.28): C, 76.48; H, 5.21; N, 5.57. 
Found: C, 76.27; H, 5.23; N, 5.54%. 
2-(4-Cyanophenyl)indole (23) was prepared from N-Boc 2-(4-
cyanophenyl)indole (2b, 0.64 g). 
Eluent: CH2Cl2. 
Yield: 46% (0.20 g). 
Yellow powder. 
Mp 192 °C. 
1H NMR (200 MHz, CDCl3):  6.94 (d, 1H, J = 2.2 Hz), 7.10-7.28 
(m, 2H), 7.42 (dd, 1H, J = 8.1, 7.5 Hz), 7.65 (d, 1H, J = 7.5 Hz), 
7.68-7.74 (m, 2H), 7.85-7.88 (m, 2H), 8.37 (s, 1H). 
13C NMR (50 MHz, CDCl3):  101.1, 111.5, 112.7, 117.8, 120.7, 
121.6, 123.2, 128.7, 131.5 (2C), 133.3 (2C), 136.1, 136.9, 141.3. 
HRMS: calcd for C15H10N2 (M
+) 218.0844, found 218.0858. 
These data were found identical to those previously described.58 
5-Fluoro-2-(4-trifluoromethylphenyl)indole (25) was prepared 
from N-Boc 5-fluoro-2-(4-trifluoromethylphenyl)indole (3, 0.77 
g). 
Eluent: heptane/CH2Cl2 50/50. 
Yield: 46% (0.26 g). 
Yellow powder. 
Mp 162 °C. 
1H NMR (200 MHz, CDCl3):  6.88 (d, 1H, J = 1.5 Hz), 6.98 
(ddd, 1H, J = 11.6, 9.1, 2.5 Hz), 7.24-7.38 (m, 2H), 7.65-7.80 (m, 
4H), 8.36 (s, 1H). 
HRMS: calcd for C15H9F4N (M
+) 279.0671, found 279.0652. 
These data were found identical to those previously described.59 
5-Bromo-2-(4-methoxycarbonylphenyl)indole (26) was pre-
pared from N-Boc 5-bromo-2-(4-methoxycarbonylphenyl)indole 
(4a, 0.88 g). 
Eluent: heptane/CH2Cl2 50/50. 
Yield: 31% (0.20 g). 
Yellow powder. 
Mp 204 °C. 
1H NMR (200 MHz, CDCl3):  3.90 (s, 3H), 6.88 (d, 1H, J = 2.0 
Hz), 7.25-7.33 (m, 2H), 7.66-7.79 (m, 3H), 8.12 (d, 2H, J = 8.6 
Hz), 8.46 (s, 1H). 
13C NMR (75 MHz, CDCl3):  52.2, 101.2, 112.5, 113.7, 123.4, 
124.8 (2C), 125.9, 129.3, 130.4 (2C), 130.8, 135.8, 135.9, 137.9, 
167.3. 
HRMS: calcd for C16H12
79BrNO2 (M
+) 329.0051, found 329.0320. 
5-Bromo-2-(4-trifluoromethylphenyl)indole (27) was prepared 
from N-Boc 5-bromo-2-(4-trifluoromethylphenyl)indole (4b, 0.89 
g). 
Eluent: heptane/CH2Cl2 60/40. 
Yield: 30% (0.20 g). 
Yellow powder. 
Mp 190 °C. 
1H NMR (200 MHz, CDCl3):  6.78 (d, 1H, J = 2.0 Hz), 7.23 (d, 
2H, J = 2.0 Hz), 7.58-7.73 (m, 5H), 8.34 (s, 1H). 
13C NMR (75 MHz, CDCl3):  101.3, 111.8, 114.7, 123.5, 124.5 
(q, J = 253 Hz), 125.6 (q, 2C, J = 3.6 Hz), 125.9, 127.7 (2C), 
129.3, 129.8 (q, J = 32 Hz), 135.7, 136.0, 140.8. 
HRMS: calcd for C15H9
79BrF3N (M
+) 338.9870, found 338.9893. 
General Procedure for the Deprotection of N-Boc Indoles 
using TBAF (Compounds 24, 28). 
To a stirred solution of the appropriate N-Boc indole (2.0 mmol) in 
THF (5 mL) at r.t. was added TBAF (8.0 mmol). The mixture was 
then heated under reflux for 10 h, and cooled at r.t. before addition 
of brine (10 mL), extraction with EtOAc (3 x 10 mL), and drying 
over Na2SO4. The solvents were removed under reduced pressure 
before purification by chromatography over silica gel (eluent 
given in the product description). 
2-(4-Trifluoromethylphenyl)indole (24) was prepared from N-
Boc 2-(4-trifluoromethylphenyl)indole (2c, 0.76 g). 
Eluent: heptane/CH2Cl2 50/50. 
Yield: 55% (0.29 g). 
White powder. 
Mp 228 °C. 
1H NMR (200 MHz, CDCl3):  6.93 (dd, 1H, J = 2.0, 1.0 Hz), 
7.10-7.29 (m, 2H), 7.43 (d, 1H, J = 7.5 Hz), 7.62-7.81 (m, 5H), 
8.39 (s, 1H). 
13C NMR (75 MHz, CDCl3):  101.5, 110.7, 110.8, 119.5, 120.2, 
122.4, 123.9 (q, J = 226 Hz), 124.6 (2C), 125.3 (q, 2C, J = 4.1 
Hz), 128.3 (q, J = 38 Hz), 135.5, 135.8, 137.4. 
HRMS: calcd for C15H10F3N (M
+) 261.0765, found 261.0745. 
These data were found identical to those previously described.59 
2-(2-Pyridyl)indole (28) was prepared from N-Boc 2-(2-
pyridyl)indole (2e, 0.60 g). 
Eluent: CH2Cl2. 
Yield: 67% (0.26 g). 
Beige powder. 
Mp 153 °C. 
1H NMR (300 MHz, CDCl3):  7.04 (d, 1H, J = 1.5 Hz), 7.07-7.28 
(m, 3H), 7.39 (dd, 1H, J = 8.1, 1.0 Hz), 7.67 (dd, 1H, J = 7.5, 2.0 
Hz), 7.75 (dd, 1H, J = 8.1, 2.0 Hz), 7.84 (td, 1H, J = 8.1, 1.5 Hz), 
8.59 (m, 1H), 9.95 (s, 1H). 
These data were found identical to those previously described.60 
13C NMR (75 MHz, CDCl3):  100.6, 111.4, 119.8, 120.1, 121.1, 
121.9, 123.1, 129.0, 136.5, 136.6, 136.7, 148.9, 150.3. 
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HRMS: calcd for C13H10N2 (M
+) 194.0844, found 194.0851. 
General Procedure for the Deprotection of N-Boc Indoles 
using TFA Followed by the Substitution of the Chloro Group 
with Amines (Compounds 29-47). 
To a stirred solution of N-Boc 2-(2-chloro-4-pyrimidyl)indole (2d, 
0.33 g, 1.0 mmol) in CH2Cl2 (5 mL) at r.t. was added TFA (15 
mmol). After 2 h at r.t., a sat. aq NaHCO3 solution (5 mL) was 
added. Extraction with EtOAc (3 x 5 mL), washing with brine (5 
mL), drying over Na2SO4, and removal of the solvents under 
reduced pressure afforded crude 2-chloro-4-(2-indolyl)pyrimidine 
which was further dissolved in a mixture of pyridine (3 mL) and 
EtOH (3 mL). The required amine (3.0 mmol) was then added, 
and the reaction mixture was heated at 150 °C for 20 min in the 
microwave oven. After removal of the solvents under reduced 
pressure, the crude product was purified by MDAP. 
4-(2-Indolyl)-N-propyl-2-pyrimidinamine (29) was prepared 
using N-propylamine (0.25 mL). 
Yield: 44% (0.11 g). 
Beige powder. 
Mp 138 °C. 
1H NMR (400 MHz, CDCl3):  1.02 (t, 3H, J = 7.5 Hz), 1.68 (m, 
2H), 3.47 (dt, 2H, J = 7.5, 4.4 Hz), 5.23 (s, 1H), 6.97 (d, 1H, J = 
5.2 Hz), 7.09 (dd, 1H, J = 2.2, 0.9 Hz), 7.12 (ddd, 1H, J = 7.9, 7.0, 
0.9 Hz), 7.26 (ddd, 1H, J = 8.3, 7.0, 1.3 Hz), 7.43 (dd, 1H, J = 8.3, 
0.9 Hz), 7.66 (dd, 1H, J = 7.9, 1.3 Hz), 8.29 (d, 1H, J = 5.2 Hz), 
9.47 (s, 1H). 
13C NMR (100 MHz, CDCl3):  11.5, 22.9, 43.4, 103.5, 105.7, 
111.5, 120.4, 121.6, 124.1, 128.7, 135.0, 136.5, 157.4, 158.0, 
162.3. 
ESCI MS: m/z 253.19, [M+H]+. 
Anal. Calcd for C15H16N4 (252.31): C, 71.40; H, 6.39; N, 22.21. 
Found: C, 71.33; H, 6.38; N, 22.26%. 
4-(2-Indolyl)-N-isobutyl-2-pyrimidinamine (30) was prepared 
using isobutylamine (0.30 mL). 
Yield: 48% (0.13 g). 
Beige powder. 
Mp 129 °C. 
1H NMR (400 MHz, CDCl3):  1.01 (d, 6H, J = 6.6 Hz), 1.94 (m, 
1H), 3.34 (t, 2H, J = 6.6 Hz), 5.29 (s, 1H), 6.97 (d, 1H, J = 5.3 
Hz), 7.10-7.16 (m, 2H), 7.26 (ddd, 1H, J = 8.3, 7.0, 1.3 Hz), 7.42 
(dd, 1H, J = 8.3, 0.9 Hz), 7.66 (dd, 1H, J = 7.9, 1.3 Hz), 8.28 (d, 
1H, J = 5.3 Hz), 9.49 (s, 1H). 
13C NMR (100 MHz, CDCl3):  20.3 (2C), 28.5, 49.1, 103.5, 
105.7, 111.5, 120.4, 121.6, 124.1, 128.7, 135.0, 136.5, 157.4, 
158.0, 162.5. 
ESCI MS: m/z 267.24, [M+H]+. 
Anal. Calcd for C16H18N4 (266.34): C, 72.15; H, 6.81; N, 21.04. 
Found: C, 72.09; H, 6.80; N, 20.98%. 
4-(2-Indolyl)-N-neopentyl-2-pyrimidinamine (31) was prepared 
using neopentylamine (0.35 mL). 
Yield: 59% (0.17 g). 
Pale yellow powder. 
Mp 134 °C. 
1H NMR (400 MHz, CDCl3):  1.02 (s, 9H), 3.36 (d, 2H, J = 6.1 
Hz), 5.22 (s, 1H), 6.96 (d, 1H, J = 5.3 Hz), 7.09-7.16 (m, 2H), 
7.26 (ddd, 1H, J = 8.3, 7.0, 1.3 Hz), 7.44 (d, 1H, J = 8.3 Hz), 7.66 
(dd, 1H, J = 7.9, 1.3 Hz), 8.27 (d, 1H, J = 5.3 Hz), 9.43 (s, 1H). 
13C NMR (100 MHz, CDCl3):  27.5 (3C), 32.0, 52.8, 103.5, 
105.7, 111.6, 120.4, 121.7, 124.1, 128.8, 135.0, 136.5, 157.4, 
158.0, 162.8. 
ESCI MS: m/z 281.03, [M+H]+. 
4-(2-Indolyl)-N-(2-trifluoromethylbenzyl)-2-pyrimidinamine 
(32) was prepared using 2-(trifluoromethyl)benzylamine (0.42 
mL). 
Yield: 45% (0.17 g). 
Beige powder. 
Mp 150 °C. 
1H NMR (400 MHz, CDCl3):  4.96 (d, 2H, J = 6.1 Hz), 5.69 (s, 
1H), 7.05 (d, 1H, J = 5.0 Hz), 7.08-7.15 (m, 2H), 7.26 (ddd, 1H, J 
= 8.3, 7.0, 1.3 Hz), 7.32-7.45 (m, 2H), 7.48 (ddd, 1H, J = 8.1, 7.9, 
1.3 Hz), 7.60-7.73 (m, 3H), 8.29 (d, 1H, J = 5.0 Hz), 9.29 (s, 1H). 
13C NMR (100 MHz, CDCl3):  41.9, 103.6, 106.4, 111.6, 120.5 
(2C), 121.6, 123.9 (q, J = 225 Hz), 124.2, 126.2 (q, J = 3.6 Hz), 
127.2, 128.8, 129.1 (q, J = 31 Hz), 132.2, 134.7, 136.5, 138.2, 
157.4, 158.3, 161.9. 
ESCI MS: m/z 368.99, [M+H]+. 
Anal. Calcd for C20H15F3N4 (368.36): C, 65.21; H, 4.10; N, 15.21. 
Found: C, 65.23; H, 4.21; N, 15.28%. 
4-(2-Indolyl)-N-(3-trifluoromethylbenzyl)-2-pyrimidinamine 
(33) was prepared using 3-(trifluoromethyl)benzylamine (0.43 
mL). 
Yield: 33% (0.12 g). 
Beige powder. 
Mp 157 °C. 
1H NMR (400 MHz, CDCl3):  4.79 (d, 2H, J = 6.1 Hz), 5.59 (s, 
1H), 7.04 (d, 1H, J = 5.3 Hz), 7.10-7.16 (m, 2H), 7.26 (ddd, 1H, J 
= 8.3, 7.0, 0.9 Hz), 7.41 (dd, 1H, J = 8.3, 0.9 Hz), 7.47 (t, 1H, J = 
7.5 Hz), 7.54 (d, 1H, J = 7.5 Hz), 7.60 (d, 1H, J = 7.5 Hz), 7.66 
(dd, 1H, J = 7.9, 0.9 Hz), 7.68 (s, 1H), 8.31 (d, 1H, J = 5.3 Hz), 
9.24 (s, 1H). 
13C NMR (100 MHz, CDCl3):  45.5, 104.0, 106.8, 111.8, 120.7, 
121.9, 124.3 (q, 2C, J = 3.7 Hz), 124.6 (q, J = 224 Hz), 124.6, 
128.9, 129.4, 130.6 (q, J = 1.5 Hz), 130.9 (q, J = 32 Hz), 134.8, 
136.8, 140.8, 157.7, 158.4, 162.3. 
ESCI MS: m/z 369.04, [M+H]+. 
Anal. Calcd for C20H15F3N4 (368.36): C, 65.21; H, 4.10; N, 15.21. 
Found: C, 65.01; H, 4.10; N, 15.11%. 
4-(2-Indolyl)-N-(4-trifluoromethylbenzyl)-2-pyrimidinamine 
(34) was prepared using 4-(trifluoromethyl)benzylamine (0.43 
mL). 
Yield: 49% (0.18 g). 
Beige powder. 
Mp 131 °C. 
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1H NMR (400 MHz, CDCl3):  4.79 (d, 2H, J = 6.1 Hz), 5.67 (s, 
1H), 7.04 (d, 1H, J = 5.2 Hz), 7.10-7.16 (m, 2H), 7.26 (ddd, 1H, J 
= 8.3, 7.0, 1.3 Hz), 7.39 (dd, 1H, J = 8.3, 0.9 Hz), 7.50 (d, 2H, J = 
8.1 Hz), 7.60 (d, 2H, J = 8.1 Hz), 7.67 (dd, 1H, J = 7.9, 0.9 Hz), 
8.29 (d, 1H, J = 5.2 Hz), 9.33 (s, 1H). 
13C NMR (100 MHz, CDCl3):  45.3, 103.9, 106.7, 111.6, 120.7, 
121.8, 124.1 (q, J = 273 Hz), 124.5, 125.6 (q, 2C, J = 3.7 Hz), 
127.6 (2C), 128.8, 129.5 (q, J = 32 Hz), 134.7, 136.7, 143.7, 
157.6, 158.3, 162.1. 
ESCI MS: m/z 368.87, [M+H]+. 
Anal. Calcd for C20H15F3N4 (368.36): C, 65.21; H, 4.10; N, 15.21. 
Found: C, 65.16; H, 4.18; N, 15.17%. 
4-(2-Indolyl)-N-(2-methoxybenzyl)-2-pyrimidinamine (35) was 
prepared using 2-methoxybenzylamine (0.39 mL). 
Yield: 50% (0.17 g). 
Beige powder. 
Mp 149 °C. 
1H NMR (400 MHz, CDCl3):  3.91 (s, 3H), 4.73 (d, 2H, J = 6.1 
Hz), 5.64 (s, 1H), 6.90-6.96 (m, 2H), 6.98 (d, 1H, J = 5.3 Hz), 
7.09 (dd, 1H, J = 2.2, 0.9 Hz), 7.12 (ddd, 1H, J = 7.9, 7.0, 0.9 Hz), 
7.23-7.30 (m, 2H), 7.38 (dd, 1H, J = 7.5, 1.3 Hz), 7.43 (dd, 1H, J 
= 8.3, 0.9 Hz), 7.66 (dd, 1H, J = 7.9, 0.9 Hz), 8.28 (d, 1H, J = 5.3 
Hz), 9.42 (s, 1H). 
13C NMR (100 MHz, CDCl3):  41.1, 55.4, 103.4, 105.9, 110.4, 
111.5, 120.4, 120.6, 121.6, 124.1, 127.3, 128.6, 128.8, 129.2, 
135.0, 136.5, 157.3, 157.6, 158.1, 162.3. 
ESCI MS: m/z 330.91, [M+H]+. 
Anal. Calcd for C20H18N4O (330.38): C, 72.71; H, 5.49; N, 16.96. 
Found: C, 72.73; H, 5.57; N, 16.96%. 
4-(2-Indolyl)-N-(3-methoxybenzyl)-2-pyrimidinamine (36) was 
prepared using 3-methoxybenzylamine (0.37 mL). 
Yield: 43% (0.14 g). 
White powder. 
Mp 140 °C. 
1H NMR (400 MHz, CDCl3):  3.79 (s, 3H), 4.70 (d, 2H, J = 5.7 
Hz), 5.57 (s, 1H), 6.82 (ddd, 1H, J = 8.3, 2.6, 0.9 Hz), 6.95-7.02 
(m, 2H), 7.00 (d, 1H, J = 5.3 Hz), 7.09-7.15 (m, 2H), 7.23-7.31 
(m, 2H), 7.41 (dd, 1H, J = 8.3, 0.9 Hz), 7.65 (dd, 1H, J = 7.9, 0.9 
Hz), 8.28 (d, 1H, J = 5.3 Hz), 9.32 (s, 1H). 
13C NMR (100 MHz, CDCl3):  45.7, 55.2, 103.5, 106.2, 111.5, 
112.6, 113.1, 119.6, 120.4, 121.6, 124.2, 128.7, 129.7, 134.8, 
136.5, 141.1, 157.4, 158.2, 159.9, 162.1. 
ESCI MS: m/z 330.91, [M+H]+. 
Anal. Calcd for C20H18N4O (330.38): C, 72.71; H, 5.49; N, 16.96. 
Found: C, 72.77; H, 5.54; N, 17.04%. 
4-(2-Indolyl)-N-(4-methoxybenzyl)-2-pyrimidinamine (37) was 
prepared using 4-methoxybenzylamine (0.39 mL). 
Yield: 42% (0.14 g). 
Beige powder. 
Mp 161 °C. 
1H NMR (400 MHz, CDCl3):  3.80 (s, 3H), 4.66 (d, 2H, J = 5.7 
Hz), 5.44 (s, 1H), 6.89 (d, 2H, J = 8.8 Hz), 7.01 (d, 1H, J = 5.3 
Hz), 7.10-7.15 (m, 2H), 7.26 (ddd, 1H, J = 8.3, 7.0, 1.3 Hz), 7.33 
(d, 2H, J = 8.8 Hz), 7.41 (dd, 1H, J = 8.3, 0.9 Hz), 7.66 (dd, 1H, J 
= 7.9, 0.9 Hz), 8.28 (d, 1H, J = 5.3 Hz), 9.33 (s, 1H). 
13C NMR (100 MHz, CDCl3):  45.2, 55.3, 103.5, 106.1, 111.5, 
114.1 (2C), 120.4, 121.6, 124.2, 128.7, 128.8 (2C), 131.3, 134.9, 
136.5, 157.4, 158.2, 158.9, 162.1. 
ESCI MS: m/z 330.91, [M+H]+. 
Anal. Calcd for C20H18N4O (330.38): C, 72.71; H, 5.49; N, 16.96. 
Found: C, 72.65; H, 5.47; N, 16.87%. 
N-(2-Chlorobenzyl)-4-(2-indolyl)-2-pyrimidinamine (38) was 
prepared using 2-chlorobenzylamine (0.36 mL). 
Yield: 36% (0.12 g). 
White powder. 
Mp 153 °C. 
1H NMR (400 MHz, CDCl3):  4.83 (d, 2H, J = 6.1 Hz), 5.66 (s, 
1H), 7.01 (d, 1H, J = 5.1 Hz), 7.10 (dd, 1H, J = 1.7, 0.9 Hz), 7.12 
(ddd, 1H, J = 7.9, 7.0, 0.9 Hz), 7.20-7.29 (m, 3H), 7.38-7.50 (m, 
3H), 7.65 (dd, 1H, J = 7.9, 0.9 Hz), 8.29 (d, 1H, J = 5.1 Hz), 9.38 
(s, 1H). 
13C NMR (100 MHz, CDCl3):  43.5, 103.8, 106.6, 111.8, 120.7, 
121.9, 124.4, 127.2, 128.8, 128.9, 129.5, 129.8, 133.6, 135.0, 
136.8, 137.0, 157.7, 158.4, 162.3. 
ESCI MS: m/z 334.91, 336.85 [M+H]+. 
Anal. Calcd for C19H15ClN4 (334.80): C, 68.16; H, 4.52; N, 16.73. 
Found: C, 68.12; H, 4.62; N, 16.58%. 
N-(3-Chlorobenzyl)-4-(2-indolyl)-2-pyrimidinamine (39) was 
prepared using 3-chlorobenzylamine (0.37 mL). 
Yield: 10% (33 mg). 
White powder. 
Mp 160 °C. 
1H NMR (400 MHz, CDCl3):  4.73 (d, 2H, J = 5.8 Hz), 5.57 (s, 
1H), 7.02 (d, 1H, J = 5.3 Hz), 7.11 (dd, 1H, J = 2.2, 0.9 Hz), 7.13 
(ddd, 1H, J = 7.9, 7.0, 0.9 Hz), 7.24-7.33 (m, 4H), 7.41-7.43 (m, 
2H), 7.66 (dd, 1H, J = 7.9, 0.9 Hz), 8.30 (d, 1H, J = 5.3 Hz), 9.24 
(s, 1H). 
13C NMR (100 MHz, CDCl3):  45.2, 103.8, 106.6, 111.7, 120.6, 
121.8, 124.3, 125.5, 127.5 (2C), 128.8, 130.0, 134.6, 134.8, 136.6, 
141.7, 157.6, 158.3, 162.1. 
ESCI MS: m/z 334.99, 336.97 [M+H]+. 
N-(4-Chlorobenzyl)-4-(2-indolyl)-2-pyrimidinamine (40) was 
prepared using 4-chlorobenzylamine (0.37 mL). 
Yield: 12% (40 mg). 
Beige powder. 
Mp 162 °C. 
1H NMR (400 MHz, CDCl3):  4.70 (d, 2H, J = 6.1 Hz), 5.51 (s, 
1H), 7.03 (d, 1H, J = 5.3 Hz), 7.12 (dd, 1H, J = 2.1, 0.9 Hz), 7.13 
(ddd, 1H, J = 7.9, 7.0, 0.9 Hz), 7.26 (ddd, 1H, J = 8.3, 7.0, 1.3 
Hz), 7.30-7.36 (m, 4H), 7.41 (dd, 1H, J = 8.3, 0.9 Hz), 7.66 (dd, 
1H, J = 7.9, 1.3 Hz), 8.29 (d, 1H, J = 5.3 Hz), 9.27 (s, 1H). 
13C NMR (100 MHz, CDCl3):  45.2, 104.0, 106.7, 111.8, 120.7, 
121.9, 124.5, 128.9, 129.0 (2C), 129.1 (2C), 133.2, 134.9, 136.8, 
138.1, 157.7, 158.4, 162.3. 
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ESCI MS: m/z 335.03, 337.02 [M+H]+. 
N-(2-Fluorobenzyl)-4-(2-indolyl)-2-pyrimidinamine (41) was 
prepared using 2-fluorobenzylamine (0.34 mL). 
Yield: 41% (0.13 g). 
White powder. 
Mp 146 °C. 
1H NMR (400 MHz, CDCl3):  4.78 (d, 2H, J = 6.1 Hz), 5.71 (s, 
1H), 7.01 (d, 1H, J = 5.3 Hz), 7.05-7.15 (m, 4H), 7.22-7.29 (m, 
2H), 7.40-7.47 (m, 2H), 7.66 (dd, 1H, J = 7.9, 0.9 Hz), 8.28 (d, 
1H, J = 5.3 Hz), 9.45 (s, 1H). 
13C NMR (100 MHz, CDCl3):  39.2, 103.8, 106.5, 111.8, 115.3 
(d, J = 21 Hz), 120.6, 121.9, 124.4, 124.5 (d, J = 3.7 Hz), 126.3 (d, 
J = 15 Hz), 129.0 (d, J = 8.1 Hz), 129.2, 129.9 (d, J = 4.4 Hz), 
135.0, 136.8, 157.6, 158.4, 161.0 (d, J = 245 Hz), 162.3. 
ESCI MS: m/z 318.86, [M+H]+. 
Anal. Calcd for C19H15FN4 (318.35): C, 71.68; H, 4.75; N, 17.60. 
Found: C, 71.52; H, 4.83; N, 17.58%. 
4-(2-Indolyl)-N-(4-tert-butylbenzyl)-2-pyrimidinamine (42) 
was prepared using 4-tert-butylbenzylamine (0.53 mL). 
Yield: 43% (0.15 g). 
White powder. 
Mp 162 °C. 
1H NMR (400 MHz, CDCl3):  1.33 (s, 9H), 4.71 (d, 2H, J = 5.7 
Hz), 5.54 (s, 1H), 7.01 (d, 1H, J = 5.3 Hz), 7.11 (dd, 1H, J = 2.2, 
0.9 Hz), 7.13 (ddd, 1H, J = 7.9, 7.0, 0.9 Hz), 7.26 (ddd, 1H, J = 
8.3, 7.0, 1.3 Hz), 7.33-7.44 (m, 5H), 7.66 (dd, 1H, J = 7.9, 1.3 
Hz), 8.28 (d, 1H, J = 5.3 Hz), 9.34 (s, 1H). 
13C NMR (100 MHz, CDCl3):  31.6 (3C), 34.7, 45.6, 103.7, 
106.3, 111.8, 120.6, 121.7, 124.4, 125.8 (2C), 127.4 (2C), 128.9, 
135.1, 136.5, 136.7, 150.6, 157.6, 158.4, 162.4. 
Anal. Calcd for C23H24N4 (356.46): C, 77.50; H, 6.79; N, 15.72. 
Found: C, 77.62; H, 6.97; N, 15.29%. 
4-(2-Indolyl)-N-(3,4,5-trimethoxybenzyl)-2-pyrimidinamine 
(43) was prepared using 3,4,5-trimethoxybenzylamine (0.51 mL). 
Yield: 37% (0.14 g). 
Beige powder. 
Mp 143 °C. 
1H NMR (400 MHz, CDCl3):  3.82 (s, 6H), 3.84 (s, 3H), 4.65 (d, 
2H, J = 5.7 Hz), 5.65 (s, 1H), 6.62 (s, 2H), 7.02 (d, 1H, J = 5.3 
Hz), 7.10-7.15 (m, 2H), 7.25 (ddd, 1H, J = 8.3, 7.0, 1.3 Hz), 7.39 
(dd, 1H, J = 8.3, 0.9 Hz), 7.66 (dd, 1H, J = 7.9, 0.9 Hz), 8.29 (d, 
1H, J = 5.3 Hz), 9.44 (s, 1H). 
13C NMR (100 MHz, CDCl3):  46.3, 56.3 (2C), 61.1, 103.9, 
104.5 (2C), 106.5, 111.7, 120.7, 121.9, 124.5, 128.7, 134.7, 135.0, 
136.6, 137.1, 153.4 (2C), 157.5, 158.1, 162.1. 
ESCI MS: m/z 391.04, [M+H]+. 
Anal. Calcd for C22H22N4O3 (390.44): C, 67.68; H, 5.68; N, 14.35. 
Found: C, 67.51; H, 5.72; N, 14.01%. 
4-(2-Indolyl)-N-(2-pyridylmethyl)-2-pyrimidinamine (44) was 
prepared using 2-(aminomethyl)pyridine (0.31 mL). 
Yield: 73% (0.22 g). 
Beige powder. 
Mp 178 °C. 
1H NMR (400 MHz, CDCl3):  4.84 (d, 2H, J = 5.7 Hz), 6.22 (s, 
1H), 7.01 (d, 1H, J = 5.1 Hz), 7.09 (dd, 1H, J = 2.2, 0.9 Hz), 7.11 
(ddd, 1H, J = 7.9, 7.0, 0.9 Hz), 7.17-7.22 (m, 1H), 7.26 (ddd, 1H, 
J = 8.3, 7.0, 1.3 Hz), 7.37 (d, 1H, J = 7.9 Hz), 7.43 (ddd, 1H, J = 
8.3, 1.7, 0.9 Hz), 7.63-7.68 (m, 2H), 8.31 (d, 1H, J = 5.1 Hz), 8.61 
(ddd, 1H, J = 4.8, 1.8, 0.9 Hz), 9.49 (s, 1H). 
13C NMR (100 MHz, CDCl3):  47.2, 103.7, 106.4, 111.8, 120.6, 
121.7, 121.8, 122.4, 124.4, 128.9, 135.1, 136.8, 136.9, 149.3, 
157.6, 158.3, 158.4, 162.3. 
ESCI MS: m/z 302.05, [M+H]+. 
Anal. Calcd for C18H15N5 (301.35): C, 71.74; H, 5.02; N, 23.24. 
Found: C, 71.48; H, 4.98; N, 23.26%. 
N-(3-Furylmethyl)-4-(2-indolyl)-2-pyrimidinamine (45) was 
prepared using 3-furylmethylamine (0.26 mL). 
Yield: 65% (0.19 g). 
Pale brown powder. 
Mp 144 °C. 
1H NMR (400 MHz, CDCl3):  4.72 (d, 2H, J = 5.7 Hz), 5.53 (s, 
1H), 6.27-6.36 (m, 2H), 7.03 (d, 1H, J = 5.3 Hz), 7.12 (dd, 1H, J = 
2.2, 0.9 Hz), 7.13 (ddd, 1H, J = 7.9, 7.0, 0.9 Hz), 7.27 (ddd, 1H, J 
= 8.3, 7.0, 1.3 Hz), 7.38 (dd, 1H, J = 1.8, 0.9 Hz), 7.43 (ddd, 1H, J 
= 8.3, 1.7, 0.9 Hz), 7.66 (dd, 1H, J = 7.9, 0.9 Hz), 8.30 (d, 1H, J = 
5.3 Hz), 9.41 (s, 1H). 
13C NMR (100 MHz, CDCl3):  39.1, 103.8, 106.6, 107.1, 110.7, 
111.8, 120.7, 121.9, 124.5, 128.9, 135.0, 136.8, 142.2, 152.8, 
157.6, 158.3, 162.1. 
ESCI MS: m/z 291.05, [M+H]+. 
N-Cyclohexyl-4-(2-indolyl)-2-pyrimidinamine (46) was pre-
pared using cyclohexylamine (0.34 mL). 
Yield: 70% (0.20 g). 
Pale yellow powder. 
Mp 114 °C. 
1H NMR (400 MHz, CDCl3):  1.18-1.35 (m, 2H), 1.39-1.53 (m, 
2H), 1.60-1.72 (m, 2H), 1.73-1.84 (m, 2H), 2.01-2.14 (m, 2H), 
3.87-4.00 (m, 1H), 5.08 (d, 1H, J = 7.9 Hz), 6.95 (d, 1H, J = 5.3 
Hz), 7.10 (dd, 1H, J = 1.8, 0.9 Hz), 7.13 (ddd, 1H, J = 7.9, 7.0, 0.9 
Hz), 7.26 (ddd, 1H, J = 8.3, 7.0, 1.3 Hz), 7.43 (dd, 1H, J = 8.3, 0.9 
Hz), 7.66 (dd, 1H, J = 7.9, 1.3 Hz), 8.27 (d, 1H, J = 5.3 Hz), 9.36 
(s, 1H). 
13C NMR (100 MHz, CDCl3):  25.1 (2C), 26.0, 33.5 (2C), 49.9, 
103.7, 105.8, 111.7, 120.6, 121.8, 124.3, 129.0, 135.2, 136.7, 
157.6, 158.3, 161.8. 
ESCI MS: m/z 292.89, [M+H]+. 
4-(2-Indolyl)-N-(N-methyl-4-piperidyl)-2-pyrimidinamine (47) 
was prepared using 4-amino-N-methylpiperidine (0.34 g). 
Yield: 50% (0.15 g). 
Pale yellow oil. 
1H NMR (400 MHz, CDCl3):  1.57-1.71 (m, 2H), 2.07-2.16 (m, 
2H), 2.23 (t, 2H, J = 11 Hz), 2.33 (s, 3H), 2.82 (d, 2H, J = 11 Hz), 
3.95 (m, 1H), 5.06 (d, 1H, J = 7.9 Hz), 6.98 (d, 1H, J = 5.3 Hz), 
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7.11 (dd, 1H, J = 1.8, 0.9 Hz), 7.13 (ddd, 1H, J = 7.9, 7.0, 1.3 Hz), 
7.26 (ddd, 1H, J = 8.1, 7.0, 0.9 Hz), 7.43 (d, 1H, J = 8.1 Hz), 7.66 
(dd, 1H, J = 7.9, 0.9 Hz), 8.28 (d, 1H, J = 5.3 Hz), 9.36 (s, 1H). 
13C NMR (100 MHz, CDCl3):  32.6 (2C), 46.5, 47.6, 54.7 (2C), 
103.8, 106.1, 111.8, 120.7, 121.9, 124.4, 130.0, 135.1, 136.7, 
157.7, 158.3, 161.9. 
ESCI MS: m/z 292.89, [M+H]+. 
Acknowledgment 
We gratefully acknowledge the financial support of Région 
Bretagne, CNRS and GlaxoSmithKline (A.S.). We thank Michel 
Vaultier for his contribution to this study. 
References 
(1) (a) Stanforth, S. P. Tetrahedron 1998, 54, 263-303. (b) 
Hassan, J.; Sévignon, M.; Gozzi, C.; Schulz, E.; Lemaire, 
M. Chem. Rev. 2002, 102, 1359-1469. (c) Handbook of 
Organopalladium Chemistry for Organic Synthesis; Ed.: 
Negishi, E.-i.; Wiley-Interscience: New York, 2002, Vol. 1, 
Chapter III. (d) Chinchilla, R.; Nájera, C.; Yus, M. Chem. 
Rev. 2004, 104, 2667-2722. (e) Chinchilla, R.; Nájera, C.; 
Yus, M. Arkivoc 2007, 152-231. 
(2) Kotha, S.; Lahiri, K.; Kashinath, D. Tetrahedron 2002, 58, 
9633-9695, and references cited therein. 
(3) Stille, J. K. Angew. Chem. Int. Ed. Engl. 1986, 25, 508-524. 
(4) (a) Negishi, E.-i.; King, A. O.; Okukado, N. J. Org. Chem. 
1977, 42, 1821-1823. (b) Negishi, E.-i. Acc. Chem. Res. 
1982, 15, 340-348. (c) Negishi, E.-i. Metal-Catalyzed 
Cross-Coupling Reactions, Eds.: Diederich, F.; Stang, P. J.; 
Wiley-VCH, New York, 1998, Chapter 1. 
(5) (a) Erdik, E. Organozinc Reagents in Organic Synthesis; 
CRC Press: New York, 1996. (b) Organozinc Reagents, 
Eds.: Knochel, P.; Jones, P.; Oxford University Press: 
Marburg, 1999. 
(6) Miller, J. A.; Farrell, R. P. Tetrahedron Lett. 1998, 39, 
7275-7278. 
(7) (a) Kondo, Y.; Takazawa, N.; Yamazaki, C.; Sakamoto, T. 
J. Org. Chem. 1994, 59, 4717-4718. (b) Kondo, Y.; 
Komine, T.; Fujinami, M.; Uchiyama, M.; Sakamoto, T. J. 
Comb. Chem. 1999, 1, 123-126. (c) Uchiyama, M.; 
Furuyama, T.; Kobayashi, M.; Matsumoto, Y.; Tanaka, K. 
J. Am. Chem. Soc. 2006, 128, 8404-8405. See also: (d) 
Kneisel, F. F.; Dochnahl, M.; Knochel, P. Angew. Chem., 
Int. Ed. 2004, 43, 1017-1021. 
(8) (a) Kondo, Y.; Shilai, M.; Uchiyama, M.; Sakamoto, T. J. 
Am. Chem. Soc. 1999, 121, 3539-3540. (b) L'Helgoual'ch, 
J. M.; Seggio, A.; Chevallier, F.; Yonehara, M.; Jeanneau, 
E.; Uchiyama, M.; Mongin, F. J. Org. Chem., 2008, 73, 
177-183. See also: (c) Wunderlich, S. H.; Knochel, P. 
Angew. Chem. Int. Ed. 2007, 46, 7685-7688. 
(9) Gauthier, D. R., Jr.; Szumigala, R. H., Jr.; Dormer, P. G.; 
Armstrong, J. D., III; Volante, R. P.; Reider, P. J. Org. Lett. 
2002, 4, 375-378. 
(10) Mutule, I.; Suna, E. Tetrahedron 2005, 61, 11168-11176. 
(11) Negishi, E.-i.; Luo, F.-T.; Frisbee, R.; Matsushita, H. 
Heterocycles 1982, 18, 117-122. 
(12) Seggio, A.; Jutand, A.; Priem, G.; Mongin, F. Synlett 2008, 
2955-2960. 
(13) For the use of PdCl2(dppf) as a highly effective catalyst for 
the coupling of organozinc reagents, see: Hayashi, T.; 
Konishi, M.; Kobri, Y.; Kumada, M.; Higuchi, T.; Hirotsu, 
K. J. Am. Chem. Soc. 1984, 106, 158-163. 
(14) For palladium-catalyzed cross-couplings of arylzinc 
compounds with aryl bromides, see for example: (a) 
Amatore, C.; Jutand, A.; Negri, S.; Fauvarque, J.-F. J. 
Organomet. Chem. 1990, 390, 389-398; (b) Bumagin, N. 
A.; Sokolova, A. F.; Beletskaya, I. P. Russ. Chem. Bull. 
1993, 42, 1926-1927; (c) Borner, R. C.; Jackson, R. F. W. J. 
Chem. Soc., Chem. Commun. 1994, 845-846; (d) 
Goldfinger, M. B.; Crawford, K. B.; Swager, T. M. J. Am. 
Chem. Soc. 1997, 119, 4578-4593; (e) Hargreaves, S. L.; 
Pilkington, B. L.; Russell, S. E.; Worthington, P. A. 
Tetrahedron Lett. 2000, 41, 1653-1656; (f) Loren, J. C.; 
Siegel, J. S. Angew. Chem. Int. Ed. 2001, 40, 754-757; (g) 
Alami, M.; Peyrat, J.-F.; Belachmi, L.; Brion, J.-D. Eur. J. 
Org. Chem. 2001, 4207-4212; (h) Karig, G.; Thasana, N.; 
Gallagher, T. Synlett 2002, 808-810; (i) Balle, T.; Andersen, 
K.; Vedsø, P. Synthesis 2002, 1509-1512; (j) Kondolff, I.; 
Doucet, H.; Santelli, M. Organometallics 2006, 25, 5219-
5222; (k) Akao, A.; Tsuritani, T.; Kii, S.; Sato, K.; 
Nonoyama, N.; Mase, T.; Yasuda, N. Synlett 2007, 31-36. 
(15) About the direct lithiation of thiophene and 
benzo[b]thiophene, see also: (a) Jen, K.-Y.; Cava, M. P. J. 
Org. Chem. 1983, 48, 1449-1451; (b) Surry, D. S.; Fox, D. 
J.; MacDonald, S. J. F.; Spring, D. R. Chem. Commun. 
2005, 2589-2590. 
(16) The 10% yield obtained by using 4-bromoanisole could be 
explained by the absence of an electron-withdrawing group 
at the 4-position of the phenyl ring. The competitive 
formation of 2,2’-bisthiophene was also observed in 40-
50% yield. 
(17) Legault, C. Y.; Garcia, Y.; Merlic, C. A.; Houk, K. N. J. 
Am. Chem. Soc. 2007, 129, 12664-12665. 
(18) Using N-Boc indole under these conditions gave after 
subsequent reaction with iodine the 2-iodo derivative in 
68% yield as a pale yellow oil (after purification by 
chromatography on silica gel using heptane/CH2Cl2 30/70 
as eluent): 1H NMR (200 MHz, CDCl3):  1.77 (s, 9H), 
7.01 (s, 1H), 7.22-7.30 (m, 2H), 7.48 (dd, 1H, J = 7.8, 2.0 
Hz), 8.17 (d, 1H, J = 7.2 Hz); 13C NMR (50 MHz, CDCl3): 
 28.3 (3C), 74.9, 85.2, 115.4, 119.4, 121.9, 122.8, 124.2, 
131.1, 137.5, 149.2; HRMS: calcd for C13H14INO (M
+•) 
343.0069, found 343.0070; Anal. Calcd for C13H14INO 
(343.16): C, 45.50; H, 4.11; N, 4.08; Found: C, 45.47; H, 
4.10; N, 4.16%. The same compound has previously been 
prepared in 67% yield using tert-butyllithium in THF at 
–78 °C: see ref. 19. 
(19) Roy, S.; Gribble, G. W. Tetrahedron Lett. 2005, 46, 1325-
1328. 
(20) For palladium-catalyzed cross-couplings of arylzinc 
compounds with aryl chlorides, see for example: (a) 
Bracher, F.; Hildebrand, D. Tetrahedron 1994, 50, 12329-
12336; (b) Amat, M.; Hadida, S.; Pshenichnyi, G.; Bosch, J. 
J. Org. Chem. 1997, 62, 3158-3175; (c) Herrmann, W. A.; 
Bohm, V. P. W.; Reisinger, C.-P. J. Organomet. Chem. 
1999, 576, 23-41; (d) Dai, C.; Fu, G. C. J. Am. Chem. Soc. 
2001, 123, 2719-2724; (e) Simkovsky, N. M.; Ermann, M.; 
Roberts, S. M.; Parry, D. M.; Baxter, A. D. J. Chem. Soc., 
Perkin Trans. 1 2002, 1847-1849; (f) Li, G. Y. J. Org. 
Chem. 2002, 67, 3643-3650; (g) Lützen, A.; Hapke, M.; 
Staats, H.; Bunzen, J. Eur. J. Org. Chem. 2003, 3948-3957; 
(h) Stanetty, P.; Schnürch, M.; Mihovilovic, M. D. Synlett 
2003, 1862-1864; (i) Milne, J.; Buchwald, S. L. J. Am. 
Chem. Soc. 2004, 126, 13028-13032; (j) Switzer, C.; Sinha, 
S.; Kim, P. H.; Heuberger, B. D. Angew. Chem. Int. Ed. 
2005, 44, 1529-1532. 
(21) Benzo[b]furan has previously been metalated using tert-
butyllithium in diethyl ether at –78 °C: Zhang, H.; Larock, 
R. C. J. Org. Chem. 2002, 67, 7048-7056. 
(22) No reaction takes place in the absence of transition metal. 
Note that product 5a has previously been obtained by 
addition of 2-benzo[b]furyllithium at the 4-position of 2-
chloropyrimidine followed by rearomatization using DDQ 
in 38% yield: see ref. 23. For previously described 
17 Synthesis  
Template for SYNLETT and SYNTHESIS © Thieme  Stuttgart · New York 2013-01-28 page 17 of 18 
regioselective cross-coupling using 2,4-dichloropyrimidine, 
see for example ref. 19e. 
(23) Strekowski, L.; Harden, D. B.; Grubb, W. B., III; Patterson, 
S. E.; Czarny, A.; Mokrosz, M. J.; Cegla, M. T.; Wydra, R. 
L. J. Heterocycl. Chem. 1990, 27, 1393-1400. 
(24) For the lithiation of furan, see: Ramanathan, V.; Levine, R. 
J. Org. Chem. 1962, 27, 1216-1219. 
(25) Hasan, I.; Marinelli, E. R.; Lin, L.-C. C.; Fowler, F. W.; 
Levy, A. B. J. Org. Chem. 1981, 46, 157-164. 
(26) Shirley, D. A.; Johnson, J. R.; Hendrix, J. P. J. Organomet. 
Chem. 1968, 11, 209-216. 
(27) For the deprotonation of 2-fluoropyridine using a lithium 
amide, see: (a) Gribble, G. W.; Saulnier, M. G. Heterocycles 
1993, 35, 151-169; (b) Estel, L.; Marsais, F.; Quéguiner, G. 
J. Org. Chem. 1988, 53, 2740-2744. 
(28) Hernández Franco, L.; Bal de Kier Joffé, E.; Puricelli, L.; 
Tatian, M.; Seldes, A. M.; Palermo, J. A. J. Nat. Prod. 
1998, 61, 1130-1132. 
(29) Gompel, M.; Leost, M.; Bal De Kier Joffe, E.; Puricelli, L.; 
Hernandez Franco, L.; Palermo, J.; Meijer, L. Bioorg. Med. 
Chem. Lett. 2004, 14, 1703-1707. 
(30) (a) Avila, J.; Hernandez, F. Expert Rev. Neurotherapeutics 
2007, 7, 1527-1533. (b) Jope, R. S.; Yuskaitis, C. J.; 
Beurel, E. Neurochem Res. 2007, 32, 577-595. (c) Maccioi, 
R. B.; Otth, C.; Concha, I. I.; Munoz, J. P. Eur. J. Biochem. 
2001, 268, 1518-1527. 
(31) Only one synthesis of Isomeridianin C and G has been 
reported: Hernandez Franco, L.; Palermo, J. A. Chem. 
Pharm. Bull. 2003, 51, 975-977. 
(32) For a similar conversion, see: Jaime-Figueroa, S.; Liu, Y.; 
Muchowski, J. M.; Putman, D. G. Tetrahedron Lett. 1998, 
39, 1313-1316. 
(33) Shengule, S. R.; Karuso, P. Org. Lett. 2006, 8, 4083-4084. 
(34) Jacquemard, U.; Bénéteau, V.; Lefoix, M.; Routier, S.; 
Mérour, J.-Y.; Coudert, G. Tetrahedron 2004, 60, 10039-
10047. 
(35) For similar conversions under microwave irradiation, see: 
(a) Luo, G.; Chen, L.; Poindexter, G. S. Tetrahedron Lett. 
2002, 43, 5739-5742; (b) Wang, X.; Chakrabarti, P. P.; 
Ognyanov, V. I.; Pettus, L. H.; Tamir, R.; Tan, H.; Treanor, 
J. J. S.; Gavva, N. R.; Norman, M. H. Bioorg. Med. Chem. 
Lett. 2007, 17, 6539-6545. 
(36) Isobe, M.; Kondo, S.; Nagasawa, N.; Goto, T. Chem. Lett. 
1977, 679-682. 
(37) Gottlieb, H. E.; Kotlyar, V.; Nudelman, A. J. Org. Chem. 
1997, 62, 7512-7515. 
(38) Inahashi, N.; Matsumiya, A.; Sato, T. Synlett 2008, 294-
296. 
(39) Kumar, A.; Say, M.; Boykin, D. W. Synthesis 2008, 707-
710. 
(40) Clark, R. D.; Muchowski, J. M.; Fisher, L. E.; Flippin, L. 
A.; Repke, D. B.; Souchet, M. Synthesis 1991, 871-878. 
(41) Witulski, B.; Buschmann, N.; Bergstrasser, U. Tetrahedron 
2000, 56, 8473-8480. 
(42) Takahashi, K.; Suzuki, T.; Akiyama, K.; Ikegami, Y.; 
Fukasawa, Y. J. Am. Chem. Soc. 1991, 113, 4576-4583. 
(43) Sieber, F.; Wentworth Jr., P.; Janda, K. D. J. Comb. Chem. 
1999, 1, 540-546. 
(44) Denmark, S. E.; Baird, J. D. Org. Lett. 2006, 8, 793-795. 
(45) Yasuhara, A.; Suzuki, N.; Yoshino, T.; Takeda, Y.; Sakamo-
to, T. Tetrahedron Lett. 2002, 43, 6579-6582. 
(46) Labadie, S. S.; Teng, E. J. Org. Chem. 1994, 59, 4250-
4254. 
(47) Denmark, S. E.; Baird, J. D. Org. Lett. 2004, 6, 3649-3652. 
(48) Brown, D. J.; Cowden, W. B.; Strekowski, L. Aust. J. 
Chem. 1982, 35, 1209-1214. 
(49) (a) Constable, E. C.; Sousa, L. R. J. Organomet. Chem. 
1992, 427, 125-139. (b) Bayh, O.; Awad, H.; Mongin, F.; 
Hoarau, C.; Trécourt, F.; Queguiner, G.; Marsais, F.; 
Blanco, F.; Abarca, B.; Ballesteros, R. Tetrahedron 2005, 
61, 4779-4784. 
(50) Semmelhack, M. F.; Chlenov, A.; Ho, D. M. J. Am. Chem. 
Soc. 2005, 127, 7759-7773. 
(51) Ishikura, M.; Matsuzaki, Y.; Agata, I. Heterocycles 1997, 
45, 2309-2312. 
(52) Mongin, F.; Mojovic, L.; Guillamet, B.; Trécourt, F.; 
Quéguiner, G. J. Org. Chem. 2002, 67, 8991-8994. 
(53) Li, J.-H.; Zhu, Q.-M.; Xie, Y.-X. Tetrahedron 2006, 62, 
10888-10895. 
(54) Mongin, F.; Bucher, A.; Bazureau, J. P.; Bayh, O.; Awad, 
H.; Trécourt, F. Tetrahedron Lett. 2005, 46, 7989-7992. 
(55) Gupton, J. T.; Petrich, S. A.; Hicks, F. A.; Wilkinson, D. R.; 
Vargas, M.; Hosein, K. N.; Sikorski, J. A. Heterocycles 
1998, 47, 689-702. 
(56) Vaitiekunas, A.; Miller, R. E.; Nord, F. F. J. Org. Chem. 
1951, 16, 1603-1609. 
(57) Liu, F.; Ma, D. J. Org. Chem. 2007, 72, 4844-4850. 
(58) Molander, G. A.; Canturk, B.; Kennedy, L. E. J. Org. Chem. 
2009, 74, 973-980. 
(59) Shen, M.; Leslie, B. E.; Driver, T. G. Angew. Chem., Int. 
Ed. 2008, 47, 5056-5059. 
(60) Hudkins, R. L.; Diebold, J. L.; Marsh, F. D. J. Org. Chem. 
1995, 60, 6218-6220. 
 
18 Synthesis  




























Cross-couplings of lithium arylzincates/Synthesis of Isomeridianine G analogues 
